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Glossary 
Amylosin A heat-stable peptide toxin produced by Bacillus spp.
which acts as a potassium and sodium ionophore 
(channel former). 
Antimycin A A toxin produced by species of Streptomyces which
inhibits mitochondrial oxidative phosphorylation. 
Bacterial toxin A toxic compound produced by bacteria. 
Cereulide The heat-stable emetic toxin produced by B. cereus
which acts as a potassium ionophore (carrier). 
Cytokine A signal molecule produced by cells of the immune 
system. 
Effective concentration 
50% / 100% (EC50 / EC100) 
Toxin exposure concentration at which 50% or 100% of 
the exposed cells exhibited the measured effect. 
Enniatin B A mycotoxin produced by Fusarium spp. which acts as
a cation ionophore (carrier). 
HaCaT cells A spontaneously immortalized human keratinocyte cell 
line originating from adult human skin and exhibiting 
normal differentiation. 
Inflammasome A cytoplasmic complex of molecules in cells of the
innate immune system which triggers inflammatory 
responses by activating caspase-1, leading leads to
active cytokine release. 
Ionophore A lipid-soluble compound that can transport ions across 
a lipid membrane. An ionophore can either act as a
carrier or form a channel. 
JC-1 A fluorogenic transmembrane potential-responsive dye
which emits orange fluorescence when ΔΨ > 140 mV
and green fluorescence when ΔΨ ≤ 100 mV. 
Macrophage A white blood cell present in all tissues that removes 
foreign material by phagocytosis as part of the innate
immune system. It can also activate adaptive immune 
reactions. Macrophages develop from monocytes. 
Microbial toxin A toxic compound produced by bacteria or fungi. 
Mitochondriotoxin / 
mitochondrial toxin 
A compound which adversely affects mitochondria or 
specific mitochondrial functions. 
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Moisture-damaged building A building in which structures have been exposed to 
dampness leading to structural damage and microbial 
growth. 
NLRP3 A widely studied inflammasome which activates 
caspase-1 and has a critical role in the human innate 
immune system.  
Octanol-water partition 
coefficient (KOW) 
A value depicting the polarity of a compound 
determined by comparing the solubility of the 
compound in octanol (non-polar) to the solubility in 
water (polar). The higher the value, the more non-polar 
the compound is. The value is often presented on a 
logarithmic scale (log KOW). 
Paenilide A heat-stable peptide toxin produced by Paenibacillus 
tundrae which acts as a potassium ionophore (carrier). 
Peptide toxin A toxic compound consisting of amino acids linked 
together by peptide bonds. 
Peripheral blood 
mononuclear cells 
The fraction of blood cells containing lymphocytes, 
monocytes and dendritic cells. 
Sick building syndrome A term used to describe situations in which occupants 
of a building experience health effects that appear to be 
linked to time spent in the building but no specific 
illness or cause can be identified. 
Stephacidin B A dimeric alkaloid toxin produced by Aspergillus spp.  
Valinomycin A peptide toxin produced by Streptomyces spp. which 
acts as a potassium ionophore (carrier). 
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Abstract 
Humans are exposed to microbes and microbial compounds continuously via 
environmental exposure and food in addition to our own microbiome. This thesis 
reports new empirical findings concerning the types of mitochondrial toxins present 
in food and indoor air and the effects of these toxins on mammalian cells. 
Dust and aerosolized compounds collected from moisture-damaged buildings were 
shown to have mitochondriotoxic effects detectable with a boar sperm motility 
inhibition (BSMI) assay. Toxin-producing bacteria isolated from the dusts and 
aerosols included producers of the mitochondrial toxins amylosin, cereulide, and 
valinomycin. In addition, aerosolized valinomycin and toxic chemical compounds 
emitted from building materials were detected using boar spermatozoa, 
demonstrating that the BMSI assay could be used to screen for mitochondrial toxicity 
in indoor air. 
Amylosin, a mitochondriotoxin produced by Bacillus spp. from indoor air and food, 
was shown to be immunotoxic: exposure of human primary macrophages to 
nanomolar concentrations of amylosin stimulated the release of inflammatory 
cytokines interleukin 1β and interleukin 18. Amylosin is the first bacterial channel-
forming ionophore toxin reported to have this effect. Low amounts of amylosin 
caused significant dose-dependent potassium ion efflux from human somatic cells 
and boar spermatozoa. Potassium efflux may be the trigger causing the observed 
cytokine release from macrophages after amylosin exposure. Amylosin also 
displayed antifungal and antibacterial activity which may give its producers a 
competitive advantage in mixed microbial communities. 
Two previously unreported food safety hazards were identified from cereal grains. A 
novel heat-stable mitochondrial toxin named paenilide, similar to cereulide 
biochemically and in mode of action, was found to be produced by Paenibacillus 
tundrae isolated from barley grains. This finding shows that the genus Paenibacillus 
cannot be considered harmless for human health. Paenilide consisted of two 
components with molecular masses equal to those of cereulide and homocereulide 
but with longer chromatographic retention times, indicating more hydrophobic 
structures than those of the cereulide compounds. Paenilide acted as a lipophilic 
potassium ionophore, causing depolarization, swelling, uncoupling of oxidative 
phosphorylation, and loss of respiratory control in isolated rat liver mitochondria. 
Paenilide accelerated glucose consumption in porcine kidney epithelial cells, causing 
metabolic acidosis, and was cytotoxic to porcine and murine cells. Paenilide was as 
toxic as cereulide at nanomolar amounts, making it a possibly potent food poisoning 
x 
agent. Paenilide was produced at incubation temperatures down to +5°C, indicating 
potential toxin formation in chilled foods. 
The second novel finding connected to cereal grains was the discovery of toxin-
producing Streptomyces spp. in healthy-looking grains of barley and spring wheat. 
The barley grain isolates, belonging to the Streptomyces albidoflavus group, 
produced the mitochondriotoxic macrolide antimycin A, a known disrupter of 
oxidative phosphorylation. The cause of the mitochondrial toxicity of the spring 
wheat grain isolates, most closely related to Streptomyces sedi, remained 
unidentified. The toxicity of the isolates and grains was detected using the BSMI 
assay, which was sensitive enough to detect nanomolar contamination corresponding 
to 2 ng of antimycin A per barley grain. Antimycin A was more toxic towards porcine 
kidney epithelial cells than the mycotoxin enniatin B but less toxic than cereulide or 
paenilide. Exposure of porcine kidney epithelial cells to these four toxins accelerated 
glucose consumption and caused mitochondrial depolarization, indicating 
upregulation of glycolysis. Pancreatic insulin-producing beta cells, however, are not 
able to switch to glycolytic ATP production and undergo necrotic cell death upon 
exposure to mitochondrial toxins. Thus, consumption of grains contaminated with 
mitochondrial toxins may especially affect pancreatic functions. 
In conlusion, the results of this thesis show that chronic exposure via indoor air or 
food to sub-lethal concentrations of mitochondriotoxins produced by spore-forming 
bacteria may be more common than known so far. This exposure may connect to the 
increasing worldwide incidence of western lifestyle diseases, such as diabetes, 
asthma, and allergies as well as cardiovascular and neurological disorders. The 
studied toxins are all heat-stable and produced by spore-formers able to withstand 
harsh environmental conditions, highlighting that preventing their presence and 
endurance in food and indoor environments is problematic.  
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Tiivistelmä (abstract in Finnish) 
Ihmiset altistuvat jatkuvasti mikrobeille ja mikrobien tuottamille yhdisteille 
ympäristön ja ruoan sekä oman elimistön kautta. Tässä väitöskirjassa esitellään uutta 
kokeellisesti kerättyä tietoa elintarvikkeissa ja sisäilmassa esiintyvistä 
mitokondriomyrkyistä ja niiden vaikutuksia nisäkässoluihin. 
Kosteusvaurioituneista rakennuksista kerättyillä pölyillä ja aerosoleilla osoitettiin 
olevan myrkyllisiä vaikutuksia mitokondrioita kohtaan. Myrkyllisyys havaittiin sian 
siittiöiden liikkuvuutta mittaavalla kokeella. Näytteistä eristettiin myrkyllisiä 
bakteereja, joiden joukossa oli kolmea tunnettua mitokondriomyrkkyä (amylosiini, 
kereulidi ja valinomysiini) tuottavia kantoja. Osoitettiin myös, että ilmassa aerosolina 
oleva valinomysiini sekä rakennusmateriaaleista haihtuvat mitokondriomyrkylliset 
kemikaalit voidaan havaita sian siittiöiden avulla. Sian siittiöiden liikkuvuutta 
mittaavaa koetta voitaisiin siis hyödyntää seulontamenetelmänä sisäilmanäytteiden 
tutkimisessa. 
Sisäilmasta ja elintarvikkeista eristettyjen Bacillus-lajien tuottaman mitokondrio-
myrkyn, amylosiinin, todettiin vaikuttavan haitallisesti ihmisen immuunijärjestelmän 
soluihin: ihmisen primääristen makrofagien altistuminen nanomolaarisille 
amylosiinipitoisuuksille johti tulehdusreaktioita edistävien sytokiinien, interleukiini 
1β:n ja interleukiini 18:n, vapautumiseen soluista. Amylosiini on ensimmäinen 
bakteeriperäinen kanavia muodostava ionoforinen myrkky, jolla tämä vaikutus on 
raportoitu. Alhaisten amylosiinimäärien osoitettiin aiheuttavan merkittävää annos-
riippuvaista kaliumionien vuotoa somaattisista ihmissoluista sekä sian siittiöistä. 
Kaliumvuoto saattaa olla tekijä, joka laukaisee sytokiinien vapautumisen 
amylosiinille altistuneista makrofageista. Amylosiinin havaittiin myös estävän 
sienten ja bakteerien kasvua, mikä voi tarjota amylosiinin tuottajille kilpailuedun 
monimuotoisissa mikrobiyhteisöissä. 
Viljan jyvistä löydettiin kaksi aiemmin tunnistamatonta elintarviketurvallisuus-
vaaraa. Ohran jyvistä eristettiin Paenibacillus tundrae -lajin kantoja, jotka tuottivat 
uutta penilidi-nimistä kuumuutta kestävää myrkkyä, joka muistutti rakenteeltaan ja 
toiminnaltaan kereulidia. Tämä löytö osoittaa, että Paenibacillus-sukua ei voida pitää 
harmittomana ihmisterveyden kannalta. Penilidi koostui kahdesta yhdisteestä, joiden 
molekyylimassat vastasivat kereulidia ja homokereulidia, mutta joiden 
kromatografiset retentioajat olivat pidemmät viitaten hydrofobisempaan 
rakenteeseen kuin kereulidikomponenteilla. Penilidi toimi lipofiilisenä kalium-
ionoforina aiheuttaen depolarisaatiota, turpoamista, oksidatiivisen fosforylaation 
irtikytkeytymistä ja hengityksen hallinnan menetystä eristetyissä rotan 
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mitokondrioissa. Penilidi kiihdytti glukoosin kulutusta sian munuaisten epiteeli-
soluissa johtaen metaboliseen happamoitumiseen (asidoosi) ja oli sytotoksinen sian 
ja hiiren soluille. Penilidi oli yhtä myrkyllistä kuin kereulidi nanomolaarisilla 
pitoisuuksilla, joten penilidiä voidaan pitää mahdollisesti vahvana ruokamyrkytysten 
aiheuttajana. Penilidiä muodostui jopa +5 °C:een lämpötilassa, joten sitä voisi 
muodostua myös kylmäsäilytetyissä elintarvikkeissa. 
Toinen viljan jyviin liittyvä uusi löydös oli myrkkyjä tuottavien Streptomyces-lajien 
löytyminen terveeltä näyttävistä ohran ja kevätvehnän jyvistä. Ohran jyvistä eristetyt 
bakteerikannat, jotka tunnistettiin Streptomyces albidoflavus -ryhmän jäseniksi, 
tuottivat mitokondrioille myrkyllistä makrolidiyhdistettä, antimysiini A:ta, joka 
tunnetaan oksidatiivisen fosforylaation häiritsijänä. Kevätvehnän jyvistä eristettyjen, 
Streptomyces sedi -lajille läheisimmin sukua olevien bakteerien myrkyllisyyden syy 
jäi tuntemattomaksi. Kaikkien eristettyjen bakteerikantojen sekä jyvien myrkyllisyys 
havaittiin sian siittiöiden liikkuvuutta mittaavalla kokeella, joka oli riittävän herkkä 
havaitsemaan saastumista, joka vastasi 2 ng antimysiini A:ta ohran jyvää kohden. 
Antimysiini A oli myrkyllisempi sian munuaisten epiteelisoluille kuin homemyrkky 
enniatiini B, mutta vähemmän myrkyllinen kuin kereulidi tai penilidi. Sian 
munuaisten epiteelisolujen altistuminen näille neljälle toksiinille kiihdytti glukoosin 
kulutusta ja aiheutti mitokondrioiden depolarisaation, mikä viittaa glykolyysin 
tehostumiseen. Sen sijaan haiman insuliinia erittävät betasolut, jotka eivät kykene 
glykolyyttiseen ATP-tuotantoon, ovat paljon haavoittuvaisempia ja päätyvät 
nekroottiseen solukuolemaan altistuessaan mitokondriomyrkyille. Mitokondrio-
myrkkyjen saastuttaman viljan syöminen voi siis haitata erityisesti haiman toimintaa. 
Tämän väitöskirjan tulokset osoittavat, että krooninen altistuminen sisäilman tai 
ruoan kautta pienille määrille itiöivien bakteerien tuottamia mitokondriomyrkkyjä 
saattaa olla yleisempää kuin tähän saakka on oletettu. Tämän kaltainen altistuminen 
voi olla yhteydessä länsimaiseen elämäntapaan liittyvien tautien, kuten diabeteksen, 
astman, allergioiden, sydän- ja verisuonitautien sekä hermostollisten häiriöiden, 
maailmanlaajuisesti kohonneeseen esiintyvyyteen. Kaikki tässä työssä tutkitut 
myrkyt ovat kuumuutta kestäviä ja itiöivien, ankaria ympäristöoloja kestävien 
bakteerien tuottamia, joten niiden läsnäolon ja säilymisen estäminen elintarvikkeissa 
tai sisätiloissa on haastavaa. 
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1. Introduction and literature review 
Humans have always been exposed to microbes everywhere from birth to death, 
through inhaled air and consumed food and water as well as all forms of surface 
contact, leading to the formation of our own internal microbiomes. Our bodies have 
adapted to life with bacteria and fungi, learning to live in harmony with some and 
combat others. However, over the past few decades, dietary transitions and the 
heightened level of hygiene especially in the Western world has diminished natural 
exposure to microbes and caused changes in our microbiomes as well as our reactions 
to external microbes. The buildings we live and work in have become more airtight 
and the air we breathe is filtered and controlled by mechanical ventilation, decreasing 
exposure to the natural microbiota present in untreated outdoor air and consequently 
increasing the exposure of inhabitants to any contaminants present in the indoor air. 
In addition, the food we eat is ever more processed to enhance the ease of use 
demanded by consumers and ensure the long shelf lives required by global trade, 
creating new types of risks to food safety. 
It is hypothesized that the changes in how we interact with our environment have led 
to changes in the microbial load our bodies are exposed to, leaving our immune 
system with few actual enemies to defend against and thus causing a tendency to 
overreact. There is a growing awareness that the modern Western way of life is 
connected to the increased incidence of conditions caused by unnecessary 
immunological responses (asthma and allergy) (reviewed by Daley 2014, Julia et al. 
2015) and inappropriate reactions to our own cells (autoimmune and 
autoinflammatory diseases such as type 1 diabetes, thyroid dysfunction, celiac 
disease, and inflammatory bowel disease) (reviewed by Egro 2013, Kondrashova et 
al. 2013, Serban 2015, Thorburn et al. 2014). On the other hand, we are most likely 
causing new types of exposures via our living environments and diet which our 
bodies have not yet become accustomed to, leading to unforeseen health impacts. 
Against this background, there is an increasing need for information on what we are 
being exposed to and what the possible results of exposure are. To this end, 
discovering novel microbially produced toxins and understanding the response of 
mammalian cells to toxin-producing microbes is of great importance. There is also a 
need to expand the use of rapid methods suitable for preliminary investigation of the 
mammalian cell toxicity of microbially produced compounds. The present study aims 
at contributing in all these areas. 
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1.1. Microbes and microbial toxins in indoor air of 
moisture-damaged buildings 
In modern societies, people spend the majority of their lives in indoor environments 
(IOM 2011). Indoor air quality is therefore considered an important factor affecting 
human health (Heseltine et al. 2009). Although exposure to microbes is essential for 
normal human health (e.g., the functioning of the digestive system) as well as the 
development and upkeep of the innate immune system (Jarchum and Pamer 2011), 
health risks related to microbial growth harbored in moisture-damaged buildings are 
of continuous and increasing concern. For example, indoor air bacteria have been 
shown to induce inflammatory and cytotoxic effects which could be related to ill-
health symptoms of inhabitants in moisture-damages sites (Hirvonen et al. 2005). 
Indoor dust and building materials contain nutrients in amounts sufficient for both 
fungal and bacterial growth, with the availability of water as the single most 
important growth limiting factor (Heseltine et al. 2009, Korpi et al. 1997). Excessive 
indoor moisture most likely therefore impacts microbial growth, and it is not 
surprising that moisture-damaged buildings are known as environments infested with 
diverse types of fungi and bacteria, many of which produce bioactive compounds 
(Heseltine et al. 2009, Thrasher and Crawley 2009, Täubel et al. 2011). Based on a 
review of published studies, it has been estimated that at least 20% of buildings in 
Europe, Canada, and the United States display signs of dampness problems (IOM 
2004), and the prevalence of dampness or mold in homes in the USA may be up to 
50% (Mudarri and Fisk 2007). Indoor dampness appears to also be an issue in 
developing countries, and overall the incidence of dampness in homes is more 
common in low-income communities in both developed and developing societies 
(Heseltine et al. 2009). It is considered likely that global climate change threatens to 
increase the amount of moisture-damaged buildings worldwide (Heseltine et al. 2009, 
IOM 2011). 
People living and/or working in moisture-damaged environments experience a wide 
range of symptoms, sometimes referred to collectively as damp building related 
illness (Wolff 2011). Symptoms vary from headaches, tiredness, and respiratory tract 
problems, such as asthma, to chronic fatigue, pseudoallergic reactions, 
gastrointestinal and neurological problems, and acute inflammatory responses (Curtis 
et al. 2004, Portnoy et al. 2005, Putus 2014). It is worth noting that the term “sick 
building syndrome”, occasionally used in the same context, actually refers to a wider 
group of building-related symptoms not solely due to moisture-related problems 
(Hodgson 1992, Wolff 2011). 
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Although no definite causal relationship between experienced symptoms and 
exposure to moisture damage has yet been shown, the prevalence of especially 
respiratory illness is reportedly higher among inhabitants of moisture-damaged 
buildings and evidence of an association between indoor dampness and asthma 
exacerbation, cough, wheeze, and upper respiratory tract symptoms has been found 
(Mendell et al. 2011). This is not surprising, since inhalation is considered the main 
exposure route leading to inflammatory, allergic, toxic or immunosuppressive effects 
through contact with epithelial cells and cells of the innate immune system within the 
lungs (Heseltine et al. 2009). An estimated 20% of asthma cases in the United States 
are connected to moisture-related issues of residential buildings (Mudarri and Fisk 
2007), and a significant portion of occupational asthma in Finland is linked to 
moisture damage in the workplace (Piipari and Keskinen 2005). The ill-health effects 
of inhabiting damp buildings cause significant costs, making moisture-damaged 
buildings a risk for both public health and national economy (Husman 2002, Mudarri 
and Fisk 2007). 
The most common fungal indicators of moisture-damaged sites are various species 
belonging to the genera Aspergillus, Penicillium, Fusarium, Cladosporium, 
Chaetomium, Stachybotrys, Acremonium, and Trichoderma; these genera include 
species known as toxin producers and inducers of allergic reactions (Heseltine et al. 
2009, Putus 2014). Fungal mycotoxins, especially trichothecenes produced by 
Stachybotrys chartarum, appear to be more common in the indoor air and dust in 
damp buildings and are considered possible causative agents of ill-health symptoms 
in damp buildings, although evidence of an association is still lacking (Heseltine et 
al. 2009). Although fungal growth is present in most cases of moisture damage, it is 
now being realized that focusing solely on fungal growth does not necessarily reflect 
how “sick” a building is: bacteria as well as both bacterial and fungal toxins must be 
taken into account as well (Nevalainen et al. 2015, Täubel et al. 2011). 
Bacteria related to moisture-damage have been less studied, but there is evidence that 
actinobacteria, especially streptomycetes and mycobacteria, are prevalent in damp 
indoor environments (Heseltine et al. 2009, Rintala et al. 2004). Toxins produced by 
Streptomyces spp. isolated from moisture-damaged buildings include valinomycin, 
nonactin, monactin, staurosporine, and chloramphenicol (Andersson et al. 1998b, 
Täubel et al. 2011). Cereulide-producing Bacillus cereus strains and amylosin-
producing Bacillus amyloliquefaciens strains have also been isolated from the indoor 
environment of moisture-damage sites (Andersson et al. 2005, Mikkola et al. 2007). 
Other toxigenic bacteria isolated from moisture-damaged indoor spaces are Bacillus 
simplex and Nocardiopsis spp. (Peltola et al. 2001a, Peltola et al. 2001b). Although 
research suggests that indoor dust contains mainly Gram positive bacteria (Rintala et 
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al. 2008), Gram negative bacteria appear more common in building materials 
(Verdier et al. 2014). It has been suggested that amounts of bacterial endotoxin 
(lipopolysaccharide, LPS) from Gram negative bacteria are higher in damp buildings, 
but contradictory reports also exist, making the role of endotoxin currently debatable 
(Heseltine et al. 2009). 
1.2. Microbes and microbial toxins in food 
Microbes affect food in many ways. While some microbes are beneficial and 
necessary for the production of certain foods (e.g. fermented foods, probiotics), many 
foods are also inviting growth environments for pathogenic bacteria and spoilage 
microbes. In the European Union, about 5 200 foodborne illness outbreaks involving 
43 000 people, 6 000 hospitalizations and 11 deaths were reported in 2013 (EFSA 
and ECDC 2015), and it is estimated that 48 million cases of foodborne illness occur 
each year in the USA, leading to nearly 128 000 hospitalizations and 3 000 deaths 
(Scallan et al. 2011a, Scallan et al. 2011b). Food safety is of growing concern also in 
the developing countries of Asia, Africa, and South and Central America, where 
foodborne illness can be seen as a threat to both human health and overall economic 
growth (Akhtar et al. 2014). Worldwide, the incidence of diarrheal diseases in 2013 
was reported to be 2.7 billion cases (Global Burden of Disease Study 2013 
Collaborators 2015), and although this figure includes diarrheal diseases contracted 
via all kinds of routes in addition to food (e.g., contaminated water supplies and 
person-to-person contact), it highlights the widespread nature of these conditions. 
With the expansion of global trade and extended shelf lives of food products, 
controlling microbial growth in foods is thus becoming more and more crucial for 
ensuring the availability of safe food for the growing global population. 
The control of food safety requires preventing the growth of food spoilage microbes 
and pathogens by physical, chemical, or biological methods. Food preservation via 
physical (e.g., high or low temperatures, reduction of water availability, ionizing 
radiation, high pressure) and chemical (e.g., addition of organic acids, enzymes, 
nitrites, sulfites, plant-derived compounds) methods was done already before the 
microbial causes of food safety issues were identified, whereas biopreservation (e.g., 
use of lactic acid bacteria and bacteriocins in non-fermented foods) is a more recent 
development in food technology (Doyle and Buchanan 2013). 
The most relevant bacteria endangering food safety worldwide based on current 
knowledge are (in alphabetical order) Bacillus cereus, Campylobacter spp., 
Clostridium botulinum, Clostridium perfringens, enterohemorrhagic Escherichia coli 
(EHEC), Listeria monocytogenes, Salmonella spp., Shigella spp., Staphylococcus 
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aureus, Yersinia enterocolitica, Y. pseudotuberculosis, and Vibrio spp. (Akhtar et al. 
2014, Doyle and Buchanan 2013, EFSA and ECDC 2015, EVIRA 2015, Scallan et 
al. 2011b). In addition, Cronobacter spp. is considered an emerging foodborne 
pathogen (Doyle and Buchanan 2013). Table 1 presents the toxins produced by these 
bacteria which are linked to food poisoning symptoms. Of these toxins, cereulide 
produced by B. cereus is known as a mitochondrial toxin. In 2014, 16.1% of 
foodborne outbreaks in the European Union were attributed to bacterial toxins with 
an increase of 82% in the total amount of reported outbreaks caused by bacterial 
toxins compared to 2010 (EFSA and ECDC 2012, EFSA and ECDC 2015). 
Table 1. Common bacterial toxins causing food poisoning. 
Toxin Producer Toxic effect 
Cytotoxic compounds 
Cytolethal 
distending toxin 
Campylobacter 
spp. 
Causes damage to DNA and disrupts 
mitosis leading to distension of host 
cells 
CPE enterotoxin Clostridium 
perfringens 
Causes Ca2+ influx into host cells 
leading to cell death 
Cytotoxin Salmonella spp. Inhibits host cell protein synthesis 
Shiga toxin 
Stx1a 
EHEC, Shigella 
dysenteriae 
Inhibits host cell protein synthesis 
Shiga toxin Stx2 
variants 
EHEC Inhibits host cell protein synthesis 
Cytotoxin K Bacillus cereus Causes host cell lysis by pore formation 
in cell membranes 
Cytotoxic and hemolytic compounds 
Nhe enterotoxin Bacillus cereus Causes host cell lysis by pore formation 
in cell membranes 
Hemolysin B Bacillus cereus Causes host cell osmotic lysis 
Neurotoxic compounds 
Botulin Clostridium 
botulinum 
Inhibits signaling at nerve-muscle 
junctions preventing voluntary muscle 
contraction and leading to flaccid 
paralysis 
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Table 1. (cont.) 
Toxin Producer Toxic effect 
Diarrheagenic compounds 
Yst enterotoxin Yersinia. 
enterocolitica 
Disrupts fluid and electrolyte transfer 
in intestinal absorptive cells 
SHET1 and 
SHET 2 
enterotoxins 
Shigella spp. Causes secretion in the small intestine 
Cholera 
enterotoxin Ctx 
Vibrio cholerae Increases Cl– secretion and decreases 
NaCl absorption in intestinal cells 
leading to osmotic water flow into the 
intestinal lumen 
Enterotoxin Salmonella spp. Causes fluid exsorption into intestinal 
lumen  
Emetic compounds 
Cereulide Bacillus cereus, 
Bacillus 
weihenstephanensis 
Inhibits activity of mitochondria and 
induces vomiting by stimulating the 
afferent vagus nerve  
Staphylococcal 
enterotoxins 
Staphylococcus 
aureus 
Induce vomiting by stimulating neural 
receptors in the abdomen and possibly 
act as superantigens causing 
overactivation of innate immunity  
Compiled from chapters 10 – 21 of Doyle and Buchanan (2013). 
Bacteria are naturally not the only harmful foodborne microbial agents. Mycotoxin 
production connected to fungal growth poses a serious threat for food safety of 
especially stored commodities such as grains. The mycotoxins most relevant for food 
and feed safety are aflatoxins produced by Aspergillus spp., ochratoxins produced by 
Aspergillus and Penicillium spp, and fumonisins, deoxynivalenol, and zearalenone, 
all produced by Fusarium spp. (Doyle and Buchanan 2013). Mycotoxins can have 
neurotoxic, nephrotoxic, hepatotoxic, carcinogenic, teratogenic as well as immuno-
suppressive effects, and usually these effects are not immediately apparent but rather 
a result of long-term exposure (Doyle and Buchanan 2013). In recent years, 
beauvericin, enniatins, fusaproliferin, and moniliformin produced by Fusarium spp. 
have been noted as emerging mycotoxins (Jestoi 2008). Of these, enniatins and 
beauvericin have been shown to damage mitochondria (reviewed by Jestoi 2008). In 
addition to bacteria and fungi, pathogenic viruses and protozoan parasites can also be 
transmitted via food (Doyle and Buchanan 2013). 
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1.3. Mitochondria: powerhouses, protectors, and 
suicide initiators of mammalian cells 
Mitochondria are organelles of eukaryotic cells. They are traditionally considered to 
consist of a smooth outer membrane and an inner membrane, highly folded into 
cristae, which together form two spaces, the intermembrane space and the matrix 
(Figure 1). The outer membrane is permeable to small molecules whereas the inner 
membrane is mainly impermeable and has a highly negative membrane potential 
referred to as the mitochondrial membrane potential, ∆Ψm (Scheffler 2008). Recent 
studies have shown that contrary to prior belief, mitochondria do not normally exist 
as static single organelles. Instead, although they can function in isolation, in cells 
they are mobile and form functional networks among themselves as well as 
interacting with other organelles such as the endoplasmic reticulum (Milane et al. 
2015). In addition, mitochondria are the only organelles with their own genome of 
non-nucleic DNA, which is inherited maternally. This mitochondrial DNA (mtDNA) 
encodes 13 proteins which are essential for oxidative phosphorylation (Scheffler 
2008). 
Mitochondria play a crucial role in many metabolic pathways of eukaryotic cells. 
They are the site of several energy producing reactions (see section 1.3.1.) and they 
also participate in amino acid metabolism as well as the biosynthesis of heme, 
cardiolipin, ubiquinol (coenzyme Q), and iron-sulfur centers (Scheffler 2008). The 
importance of normal mitochondrial functions is highlighted by the phenomena 
linked to mitochondrial dysfunction: the growing field of mitochondrial medicine has 
identified numerous diseases connected to hereditary or sporadic mitochondrial 
mutations and the accumulation of mutations in mtDNA is considered a possible 
cause of aging and some age-related neurodegenerative diseases, such as Parkinson’s 
and Alzheimer’s diseases (Scheffler 2008). Mitochondria also participate in the 
regulation of the innate immune system (see section 1.3.2.) and autophagy (Galluzzi 
et al. 2012, Tait and Green 2012). In addition, mitochondria are known to control one 
of the two main pathways leading to apoptosis, also known as programmed cell death 
(Wojtczak and Zablocki 2008) (see section 1.3.3.), and they possibly take part in the 
cell signaling connected to necroptosis (a form of regulated necrosis) (Galluzzi et al. 
2012). 
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Figure 1. Schematic picture of the structure of a mitochondrion. 
1.3.1. Energy production in mitochondria 
Mitochondria are crucial as energy-producing organelles in mammalian cells, as 
oxidative phosphorylation, the major source of energy in the form of ATP for aerobic 
non-photosynthetic eukaryotic cells, only occurs inside mitochondria. Oxidative 
phosphorylation occurs in the folds (cristae) of the inner membrane where enzyme 
complexes I, II, III, IV, and V are located. Other metabolic processes involved in 
energy production, the Krebs cycle (citric acid cycle) and fatty acid oxidation, take 
place in the matrix. (Scheffler 2008) 
The enzyme complexes participating in oxidative phosphorylation consist of multiple 
polypeptide subunits encoded by both mitochondrial and nuclear DNA. A schematic 
overview of oxidative phosphorylation is shown in Figure 2. In short, complexes I, 
II, III, and IV together form an electron transport chain that generates the proton 
motive force which complex V utilizes to produce ATP. NADH enters the respiratory 
chain via complex I, the NADH-ubiquinone oxidoreductase, which transfers 
electrons from NADH to ubiquinone, creating enough energy to transfer four protons 
from the matrix to the intermembrane space, thus affecting the proton gradient 
spanning the inner mitochondrial membrane. Complex II, the succinate-ubiquinone 
oxidoreductase, connects oxidative phosphorylation to the Krebs cycle: after 
oxidizing succinate to fumarate, complex II transfers the released electrons to 
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ubiquinone. Complex III, the ubiquinol-cytochrome-c reductase or bc1 complex, then 
transfers electrons from the reduced ubiquinone to cytochrome c in two steps while 
simultaneously translocating four protons from the matrix to the intermembrane 
space. Complex IV, the cytochrome-c oxidase, catalyzes the transfer of electrons 
from cytochrome c to the terminal electron acceptor, oxygen, producing primarily 
water but also reactive oxygen species (ROS); this occurs yet again in conjunction 
with the transfer of four protons into the transmembrane space. Finally, complex V, 
the F1F0-ATPase or ATP synthase, utilizes the proton motive force, generated by the 
proton gradient, as an energy source to drive the release of ATP synthesized within 
the complex using ADP and inorganic phosphate, thus turning kinetic energy into 
biochemical transferable energy. It is estimated that the production of one ATP 
requires the translocation of 3 or 4 protons back down the proton gradient into the 
mitochondrial matrix. (Nijtmans et al. 2004, Scheffler 2008) 
 
 
Figure 2. Schematic representation of the steps and complexes involved in oxidative 
phosphorylation. 
I: NADH-ubiquinone oxidoreductase; II: succinate-ubiquinone oxidoreductase; III: 
ubiquinol-cytochrome-c reductase (bc1 complex); IV: cytochrome-c oxidase; V: 
F1F0-ATPase (ATP synthase); NADH: reduced nicotinamide adenine dinucleotide; 
NAD+: oxidized nicotinamide adenine dinucleotide UQ: ubiquinone; Cyt c: 
cytochrome c; ADP: adenosine diphosphate; Pi: inorganic phosphate; ATP: 
adenosine triphosphate. 
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1.3.2. Mitochondria and innate immunity 
Mitochondria participate in different functions of the human innate immune system. 
They appear to play a role in regulating antiviral immunity and lyzosome-dependent 
degradation of unwanted cytosolic components (autophagy), and the reactive oxygen 
species produced during oxidative phosphorylation act as innate immunity signaling 
molecules (reviewed by Tait and Green 2012). Recent research indicates that 
mitochondria participate in the activation of the NLRP3 inflammasome (also known 
as NALP3 and cryopyrin), a cytosolic protein complex responsible for triggering 
inflammatory responses by activating caspase-1 which leads to the release of active 
cytokines IL-1β and Il-18 (Elliott and Sutterwala 2015, Sutterwala et al. 2014). 
The NLRP3 inflammasome has been studied extensively since it was first described 
by Martinon et al. in 2002. It has a crucial role in activating inflammatory cytokine 
production and seems to be the most relevant inflammasome from a clinical point of 
view, as it can be activated by a wide range of diverse stimuli (reviewed by 
Abderrazak et al. 2015) and is implicated in the development of many significant 
non-infectious diseases, such as type 2 diabetes, obesity, inflammatory bowel disease, 
atherosclerosis, gout, Alzheimer’s disease, as well as acute and chronic respiratory 
diseases (reviewed by De Nardo et al. 2014, Hosseinian et al. 2015, Leemans et al. 
2011, Novak and Mollen 2015). Although mitochondrial dysfunction is not a 
mandatory requisite for NLRP3 activation (Muñoz-Planillo et al. 2013), it has been 
put forward as a key activator of the NLRP3 inflammasome, as numerous signals 
produced by damaged mitochondria (e.g., release of reactive oxygen species or 
mtDNA and Ca2+ efflux into the cytoplasm) have been shown to stimulate 
inflammasome assembly (reviewed by Gurung et al. 2015). 
Activation of the NLRP3 inflammasome requires two signals. First, a priming signal 
upregulates the synthesis of NLRP3 and its post-translational modification, which is 
necessary for its oligomerization into an active form. The second step, which leads 
to the formation of an active NLRP3 inflammasome, can be triggered by many 
different types of stimuli, generally called danger signals, such as extracellular ATP, 
pore-forming toxins, phagocytized crystalline molecules (e.g., asbestos, silica), and 
endoplasmic reticulum stress. It is worth noting that although diverse stimuli can 
activate NLRP3, potassium efflux appears to always be required. Mitochondrial 
dysfunction is also considered an activator of the NLRP3 inflammasome, indicating 
that NLRP3 can sense mitochondrial damage and could possibly act as a monitor of 
mitochondrial integrity in cells. Moreover, it has been suggested that mitochondria 
act as a scaffold for NLRP3 inflammasome assembly in the activation process. 
(Elliott and Sutterwala 2015, Sutterwala et al. 2014) 
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1.3.3. Mitochondria and apoptosis 
Apoptosis (programmed cell death) can occur via two pathways, the extrinsic death 
receptor pathway and the intrinsic mitochondrial pathway. The first step in the 
mitochondrial pathway is the controlled loss of the highly negative (−160 to −180 
mV) mitochondrial inner membrane potential (loss of ∆Ψm), which leads to the 
termination of ATP production and the release of mitochondrial proteins, including 
cytochrome c, into the cytosol, triggering a catalytic process which ends in cell death 
(Galluzzi et al. 2012, Milane et al. 2015, Scheffler 2008). The controlled loss of ∆Ψm 
can occur as a result of pore formation in the outer mitochondrial membrane by pro-
apoptotic proteins of the Bcl-2 family, activated due to cellular stress such as DNA 
damage, UV radiation, Ca2+ influx or oxidative stress, or following a phenomenon 
termed mitochondrial permeability transition, in which the inner mitochondrial 
membrane becomes permeant to small solutes (Galluzzi et al. 2012, Milane et al. 
2015). 
1.4. Mitochondrial toxins 
Since mitochondria are crucial for mammalian cells in many ways, mitochondrial 
dysfunction has serious consequences. Mitochondrial toxicity induced by 
pharmaceutical drugs has led to market withdrawals, making it a focus of growing 
interest for the pharmaceutical industry (Dykens and Will 2007). There is also rising 
concern about the mitochondrial toxicity of environmental toxins such as the widely 
used antibacterial agent triclosan (Ajao et al. 2015, Newton et al. 2005), the herbicide 
paraquat, the piscicide and pesticide rotenone, cyanide, heavy metals and cigarette 
smoke (reviewed by Meyer et al. 2013). On the other hand, the crucial role of 
mitochondria in controlling cell death makes mitochondriotoxic substances 
interesting as possible agents for anticancer therapies (Fantin and Leder 2006), 
although thus far none of these “mitocans” have successfully passed clinical trials 
(reviewed by Modica-Napolitano and Weissig 2015). 
Examples of microbially produced mitochondrial toxins are listed in Table 2. Toxins 
which act as ionophores cause depolarization of the mitochondrial membrane (loss 
of ∆Ψm), which affects mitochondrial functioning in many ways (Wallace and 
Starkov 2000). The production of ATP ceases as oxidative phosphorylation becomes 
uncoupled (no proton motive force) and the influx of ions causes influx of water and 
swelling of the mitochondria. Changes also occur in the mitochondrial matrix and 
mtDNA (Coppey et al. 1999), and ultimately depolarization leads to mitophagy 
(autophagy of mitochondria) (Lemasters 2014) or cell death by apoptosis as described 
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above (section 1.3.3). Other toxins inhibit the action of specific proteins relevant for 
mitochondrial functions, such as myxothiazol which inhibits the second step in the 
transfer of electrons to cytochrome c within complex III of the mitochondrial electron 
transport chain (described in section 1.3.1) (Scheffler 2008). 
The following sections present the mitochondrial toxins studied in this thesis work. 
The known chemical structures of antimycin A, cereulide, enniatin B, and 
valinomycin are presented in Figure 3. 
 
 
 
 
Figure 3. Structures of antimycin A, cereulide, enniatin B, and valinomycin. 
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Table 2. Examples of toxic microbial compounds affecting mammalian cell 
mitochondria. 
Compound Producer References 
Inhibitors of oxidative phosphorylation complex I 
Aurachin A and B Stigmatella aurantiaca Friedrich et al. 1994 
Kalkitoxin Moorea producens Morgan et al. 2015 
Myxalamides A-D Myxococcus xanthus, Stigmatella 
aurantiaca 
Steglich et al. 2000 
Phenalamides A-C Myxococcus stipitatus Steglich et al. 2000 
Phenoxan Polyangium spp. Friedrich et al. 1994 
Piericidin A Streptomyces mobaraensis Friedrich et al. 1994 
Thiangazole Polyangium spp. Friedrich et al. 1994 
Inhibitors of oxidative phosphorylation complex II 
3-Nitropropionic acid 
(3-NPA) 
Arthrinium sp., Aspergillus flavus, 
Aspergillus oryzae, Penicillium 
atrovenetum 
Francis et al. 2013 
Inhibitors of oxidative phosphorylation complex III 
Antimycin A Streptomyces spp. Steglich et al. 2000 
Funiculosin Penicillium funiculosum Thom Nelson et al. 1977 
Myxothiazol Myxococcus fulvus Thierbach and Reichenbach 
1981 
Stigmatellin Stigmatella aurantiaca Kunze et al. 1984 
Inhibitors of oxidative phosphorylation complex IV 
Hydrogen cyanide Chromobacterium violaceum, 
Pseudomonas aeruginosa, 
Pseudomonas fluorescens, Anacystis 
nidulans, Nostoc muscorum, 
Plectonema boryanum, Rhizobium 
leguminosarum 
Blumer and Haas 2000 
Metarhizin A Metarhizium flavoviride Katou et al. 2014 
Inhibitors of oxidative phosphorylation complex V 
Aurovertins A and D Calcarisporium arbuscula Linnett and Beechey 1979 
Citreoviridin Penicillium spp. Linnett and Beechey 1979 
Efrapeptin Tolypocladium spp. Cross and Kohlbrenner 
1978, Krasnoff and Gupta 
1991 
Oligomycin A, B, and C Streptomyces diastatochromogenes  Linnett and Beechey 1979 
Calcium ionophores 
Calcimycin Streptomyces chartreusensis Reed and Lardy 1972 
Ionomycin Streptomyces conglobatus Liu and Hermann 1978 
Listeriolysin O Listeria monocytogenes Stavru and Cossart 2011 
Sodium ionophores 
Monensin Streptomyces cinnamonensis Steglich et al. 2000 
 
14 
Table 2. (cont.) 
Compound Producer References 
Potassium ionophores 
Amylosin Bacillus amyloliquefaciens,  
Bacillus subtilis, Bacillus 
mojavensis 
Apetroaie-Constantin et al. 
2009, Mikkola et al. 2004, 
Mikkola et al. 2007 
Bafilomycin Streptomyces griseus Teplova et al. 2007 
Beauvericin Fusarium spp. Tonshin et al. 2010 
Cereulide Bacillus cereus Mikkola et al. 1999 
Enniatins A, A1, B, and B1 Fusarium spp. Tonshin et al. 2010 
Narasin Streptomyces aureofaciens Wong et al. 1977 
Nonactin Streptomyces spp. Steglich et al. 2000 
Salinomycin Streptomyces albus Mitani et al. 1975 
Valinomycin Streptomyces spp. Mathews et al. 2000 
Inducers of the mitochondrial apoptosis pathway 
α-toxin (α-hemolysin) Staphylococcus aureus Rudel et al. 2010 
EspF and Map EHEC Rudel et al. 2010 
Lethal toxin Clostridium sordellii  Rudel et al. 2010 
Microcystins Anabaena spp., Microcystis spp., 
Nostoc spp., Planktothrix spp., 
Aphanizomenon spp.  
Campos and Vasconcelos 
2010 
Omp38 Acinetobacter baumanii Rudel et al. 2010 
Panton-Valentine leukocidin Staphylococcus aureus Rudel et al. 2010 
Pneumolysin Streptococcus pneumoniae Rudel et al. 2010 
PorB porin Neisseria gonorrhoeae Rudel et al. 2010 
Shiga toxin 1 Escherichia coli Lee et al. 2005 
Toxin A, toxin B 
(TcdA, TcdB) 
Clostridium difficile Rudel et al. 2010 
VacA toxin subunit p34 Helicobacter pylori Rudel et al. 2010 
Other 
Diphteria toxin subunit A: inhibits 
energy production (exact mechanism 
unknown) 
Corynebacterium 
diphtheriae 
Abraham et al. 1982 
Endotoxin / Lipopolysachharide 
(LPS): inhibits energy production 
(exact mechanism unknown) 
Gram-negative bacteria Jeger et al. 2015 
Gramicidins: form cation-specific 
pores 
Brevibacillus brevis Mathews et al. 2000 
Nigericin: K+/H+ antiport Streptomyces spp. Mathews et al. 2000, 
Steglich et al. 2000 
Staurosporine: inhibits protein kinase 
C (affects complex V) 
Streptomyces 
staurosporeus 
Gani and Engh 2010 
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1.4.1. Amylosin 
Amylosin is a heat-stable, acid and base resistant peptide toxin (1,197 Da) produced 
by strains of Bacillus amyloliquefaciens, B. subtilis and B. mojavensis (Apetroaie-
Constantin et al. 2009, Mikkola 2006, Mikkola et al. 2007). It was first identified 
from fungicidic B. amyloliquefaciens strains isolated from moisture-damaged indoor 
spaces (Mikkola et al. 2004). It is moderately lipophilic with a log KOW between 3 
and 4 (Mikkola 2006). The structure of amylosin has not been elucidated, but it is a 
linear or cyclic peptide known to contain a polyene chromophore and the amino acids 
tyrosine, proline, leucine / isoleucine, aspartic acid / asparagine, and glutamic acid / 
glutamine (Mikkola et al. 2007). 
Amylosin forms cation-selective channels in lipid membranes with high affinity for 
potassium ions compared to sodium or calcium ions (Mikkola et al. 2004, Mikkola et 
al. 2007). It inhibits boar sperm motility, is cytotoxic to feline lung cells and human 
neural cells, depolarized mitochondria in mammalian cells, and causes uncoupling of 
oxidative phosphorylation and swelling in isolated mitochondria at nanomolar 
concentrations in the presence of potassium and sodium ions (Apetroaie-Constantin 
et al. 2009, Mikkola et al. 2004, Mikkola et al. 2007).  
1.4.2. Antimycin A 
Antimycin A, a mixture of four structurally similar compounds (A1 – A4; 507 to 549 
Da) (Steglich et al. 2000), belongs to the macrolide antibiotics, although it currently 
has no therapeutic use due to its toxicity. First isolated in 1947 by Leben & Keitt as 
a compound active against phytopathogenic fungi (as reported by Riclea et al. 2012, 
Steglich et al. 2000), antimycin A is produced by several species of Streptomyces, 
including S. antibioticus, S. albus, S. albidoflavus and S. turgidiscabies (Kotiaho et 
al. 2008, Olano et al. 2014, Seipke et al. 2011, Vezina et al. 1976, Yan et al. 2010). 
The antimycin A compounds contain a bislactone ring where threonine is linked by 
an amide bond to 3-N-formylsalicylic acid, with compounds A1-A4 having different 
alkyl chains at C-7 (Steglich et al. 2000). Antimycin A is lipophilic with a log KOW 
of 5.71 (Gulden et al. 2001). 
Antimycin A inhibits mitochondrial oxidative phosphorylation by interfering with 
electron transport within complex III (Figure 2), specifically preventing electron 
transfer from cytochrome b to cytochrome c1 (Mathews et al. 2000, Scheffler 2008). 
It is toxic to birds, mammals and fish but not plant cells, as plant cell mitochondria 
possess an alternative oxidase which enables them to bypass complex III (Lennon et 
al. 1971, Millar et al. 2011). Antimycin A causes apoptosis in human liver cells as 
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well as bovine and human vascular endothelial cells and induces cell death in 
osteoblasts, and it has been suggested that these reactions may lead to atherosclerosis, 
hypertension, diabetes, and osteoporosis (Chen and Yan 2005, Choi and Lee 2011, 
Sena et al. 2013, You and Park 2010). Antimycin A is of interest as a cancer therapy 
agent model due to its ability to reverse multidrug resistance in certain types of tumor 
cells (Tzung et al. 2001). 
1.4.3. Cereulide 
Cereulide is a non-ribosomally produced cyclic dodecadepsipeptide toxin (1,152 Da) 
produced by emetic strains of Bacillus cereus and B. weihenstephanensis (reviewed 
by Stenfors Arnesen et al. 2008). It was first identified by Agata et al. from a strain 
of B. cereus isolated from an individual with emetic food poisoning (Agata et al. 
1994). Cereulide is lipophilic (calculated log KOW = 5.96 to 7.46) (Mikkola et al. 
1999, Teplova et al. 2006) and heat-stable up to 150 °C (Rajkovic et al. 2008). The 
amino acid structure of cereulide is cyclo(D-O-Leu-D-Ala-L-O-Val-L-Val-)3 (Agata 
et al. 1994). Recently, it has been reported that there are at least 19 structural cereulide 
variants which display varying cytotoxicity (Marxen et al. 2015a). 
Cereulide is an ionophore which forms stable complexes with monovalent cations, 
functioning as a carrier with high selectivity for potassium ions compared to sodium, 
calcium or ammonium ions (Mikkola et al. 1999, Teplova et al. 2006). It inhibits boar 
sperm motility, is cytotoxic to several human cell lines and porcine pancreatic beta 
cells, causes loss of ∆Ψm and osmotic swelling of mitochondria due to the uptake of 
potassium ions, and induces emesis in mammals (Agata et al. 1995, Andersson et al. 
1998a, Andersson et al. 2007, Jääskeläinen et al. 2003, Mikkola et al. 1999, Virtanen 
et al. 2008). Cereulide inhibits sperm motility by causing potassium efflux from the 
cytoplasm, leading to hyperpolarization of the plasma membrane, and also causes 
potassium influx into mitochondria, causing loss of ΔΨm (Andersson and Salkinoja-
Salonen 2005). The toxic dose causing emesis in humans is estimated as ≤8 μg kg−1 
body weight (Jääskeläinen et al. 2003). Fatal and near-fatal cases of food-related 
cereulide intoxications have been connected to liver failure and metabolic acidosis 
caused by damage to mitochondria (Dierick et al. 2005, Ichikawa et al. 2010, Mahler 
et al. 1997, Naranjo et al. 2011, Shiota et al. 2010). Sub-emetic concentrations of 
cereulide (<1 ng ml-1) have been shown to adversely effect intestinal epithelial cells 
(Rajkovic et al. 2014). The resistance of cereulide to heat, acids and proteolysis 
enhances its ability to maintain structural integrity in cooked foods and the digestive 
tract, increasing the risk of foodborne intoxication (Stenfors Arnesen et al. 2008). 
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1.4.4. Enniatin B 
Enniatin B is a lipophilic (log KOW = 6.9) cyclic hexadepsipeptide mycotoxin (640 
Da) produced by Fusarium spp. and Verticillium hemipterigenum (reviewed by Sy-
Cordero et al. 2012). It belongs to a family of closely related compounds of which 
enniatin A was first isolated by Gäumann et al. in 1947 from the mycelium of 
Fusarium orthoceras var. enniatinum as a compound with in vitro bioactivity against 
mycobacteria (Gäumann et al. 1947). The amino acid structure of enniatin B is 
cyclo(D-O-Val-L-MeVal-)3 (Blais et al. 1992). 
Enniatin B acts as a channel-forming cation ionophore with high selectivity for 
potassium ions (Kamyar et al. 2004, Tonshin et al. 2010). It inhibits boar sperm 
motility, is cytotoxic to murine macrophages, porcine kidney cells, heart muscle cells 
of guinea pigs, human liver carcinoma cells as well as fetal lung fibroblast-like cells, 
and causes loss of ∆Ψm and swelling of mitochondria (Hoornstra et al. 2003, Jestoi 
2008, Sy-Cordero et al. 2012, Tonshin et al. 2010). Enniatin B has also been shown 
to have fungicidic activity (reviewed by Sy-Cordero et al. 2012). Enniatin B is 
considered an emerging mycotoxin and has only recently been identified as a possible 
hazard for food and feed safety (Jestoi 2008). 
1.4.5. Valinomycin 
Valinomycin is a cyclic dodecadepsipeptide toxin (1,111 Da) which acts as a 
lipophilic (calculated log KOW = 4.49 to 5.99) potassium carrier similarly as cereulide 
(Mikkola et al. 1999, Teplova et al. 2006). Valinomycin was first isolated in 1955 by 
Brockmann and Schmidt-Kastner as an antibiotic effective against Mycobacterium 
tuberculosis produced by a strain of Streptomyces fulvissimus, and since then 
producers have been found to belong to several species, including S. griseus, S. 
tsusimaensis, S. anulatus, S. exfoliatus and S. araujoniae (Andersson et al. 1998b, 
Brockmann and Schmidt-Kastner 1955, Matter et al. 2009, Silva et al. 2014). The 
amino acid structure of valinomycin is cyclo(L-Val-D-O-Val-D-Val-L-O-Ala-)3 
(Steglich et al. 2000). 
Valinomycin is a highly toxic compound which uncouples oxidative 
phosphorylation, inhibits boar sperm motility, and causes loss of ∆Ψm and osmotic 
swelling of mitochondria in the presence of potassium ions (Andersson et al. 1998b, 
Hoornstra et al. 2003, Steglich et al. 2000). It has also been shown to affect human 
natural killer cells, causing inhibition of cytokine production and apoptosis 
(Paananen et al. 2000). Although valinomycin is very similar to cereulide in many 
ways, it has a lower affinity for potassium ions than cereulide, making it less toxic 
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than cereulide to mammalian cells at physiological potassium concentrations 
(Teplova et al. 2006). 
1.5. Effects of exposure to mitochondrial toxins 
1.5.1. Acute effects 
Structural differences in the respiratory chain enzymes of plants, animals and fungi 
lead to differences in sensitivity towards toxins affecting mitochondrial respiration. 
In mammals, toxins which inhibit or uncouple oxidative phosphorylation accelerate 
the use of oxygen in conjunction with decreased production of ATP. This results in 
cytotoxic hypoxia, leading to hyperpnea (increased depth of breathing) and metabolic 
acidosis as a result of glycolytic ATP production and lactate accumulation (Wallace 
and Starkov 2000). Observable symptoms include muscle weakness, fatigue, 
headaches, nausea, and confusion as well as cardiovascular symptoms such as 
hypotension and aggravated myocardial angina (Wallace and Starkov 2000). 
Acidosis provoked by aerobic glycolysis combined with mitochondrial 
depolarization after exposure to the ionophoric mitochondriotoxin triclosan has been 
shown to cause necrotic cell death (Ajao et al. 2015). In addition to the inhibitory 
effects, mitochondrial toxins affecting complex III, such as antimycin A, cause 
increased generation of harmful reactive oxygen species (Wallace and Starkov 2000).  
Several mycotoxins presented in Table 2, such as enniatin B, citreoviridin and 3-
NPA, occur naturally in food crops like grains, rice and sugar cane (Almeida et al. 
2012, Francis et al. 2013, Jestoi et al. 2004a, Jestoi et al. 2004b). 3-NPA as well as 
the bacterial toxins cereulide and amylosin are known to cause symptoms of food 
poisoning following acute exposure, with cereulide and 3-NPA connected to fatal 
human cases (Apetroaie-Constantin et al. 2009, Francis et al. 2013, Stenfors Arnesen 
et al. 2008). Citreoviridin has been connected to cases of thiamin (vitamin B1) 
deficiency, known as beriberi (Almeida et al. 2012). A case of human poisoning via 
combined inhalation and ingestion of the ionophore salinomycin showed that a dose 
of 1 mg kg-1 led to serious damage to skeletal muscles caused most likely by ATP 
depletion (Story and Doube 2004). 
Whereas foodborne exposure to toxins occurs naturally through ingestion and 
consequent absorption in the digestive tract, exposure to toxins in indoor air most 
likely occurs through inhalation of airborne particles and semivolatile compounds. 
Acute effects can therefore be expected to center on the respiratory tract and mucous 
membranes. For example, the primary symptoms experienced by individuals in 
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moisture-damage buildings tend to be flu-like, such as rhinitis, cough, sore throat, as 
well as irritation of the eyes and skin via air contact (Putus 2014). Mitochondrial 
toxins found in moisture-damaged buildings, such as acrebol (produced by 
Acremonium exuviarum), amylosin, cereulide, and valinomycin, have been shown to 
be cytotoxic to feline fetal lung cells (Andersson et al. 2005, Andersson et al. 2009, 
Mikkola et al. 2007). Cereulide and valinomycin produced by indoor air isolates also 
affect mitochondria in human lung cells (Andersson et al. 2005). These reports 
suggest that mitochondrial toxins may have direct effects on pulmonary functions. 
1.5.2. Chronic effects 
Mitochondrial dysfunction is implicated in many acquired conditions with rising 
incidence worldwide, such as cancer, diabetes, inflammatory bowel disease, 
neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Huntington’s 
diseases as well as pathological conditions of the heart and cardiovascular system, 
kidneys, liver, eyes, ears, gastrointestinal tract, and even psychiatric disorders such 
as depression and schizophrenia (reviewed by DiMauro et al. 2006, Neustadt and 
Pieczenik 2008, Novak and Mollen 2015). Toxic compounds which disrupt 
mitochondrial functions are known to affect at least the liver, cardiovascular system, 
skeletal muscles, kidneys, pancreas, and nervous system (Dykens and Will 2007, 
Eirin et al. 2014). For example, mitochondrial dysfunction is one of the main causes 
of drug-induced liver injury, which often prevents the approval of new 
pharmaceuticals and has also led to market withdrawals of clinical drugs (Labbe et 
al. 2008). 
Long-term or repeated exposure to subacute levels of toxins leading to chronic 
symptoms is an area where knowledge is currently lacking (Rajkovic 2014). Pesticide 
exposure has been linked to the rising incidence of many chronic diseases, and one 
of the mechanisms implicated as a cause is mitochondrial damage, as many pesticide 
compounds inhibit mitochondrial functions, such as oxidative phosphorylation or 
fatty acid metabolism (Mostafalou and Abdollahi 2013). Microbially produced 
mitochondrial toxins exhibit similar effects on mammalian cells and could therefore 
also add to the burden of increasing chronic diseases. For example, low doses of 
cereulide have many toxic effects on pancreatic insulin-producing beta cells, 
suggesting that chronic exposure via staple foods to low amounts of cereulide may 
contribute to the worldwide rise in the incidence of diabetes, but in vivo studies to 
confirm this hypothesis have not yet been conducted (Vangoitsenhoven et al. 2015). 
Chronic effects of mitochondrial toxins may also follow from states of chronic 
inflammation caused by continued inflammasome activation (see section 1.5.3.). For 
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example, chronic inflammation in the pulmonary tract can lead to the development 
of asthma, which is linked to exposure to damp indoor environments (Heseltine et al. 
2009, IOM 2004, Putus 2014). 
1.5.3. Immunotoxicity 
Taking into account the multifaceted role of mitochondria in controlling the reactions 
of the innate immune system (section 1.3.2), it is not surprising that mitochondrial 
dysfunction has been shown to lead to stimulation of cytokine release and therefore 
activation of the innate immune system (reviewed by Elliott and Sutterwala 2015, 
Gurung et al. 2015). Of the toxic compounds presented in Table 2, α-hemolysin, 
Panton-Valentine leucocidin, pneumolysin, TcdA, TcdB, gramicidin, nigericin, and 
LPS have been shown to activate the NLRP3 inflammasome, and valinomycin has 
been reported to stimulate active cytokine IL-1β release from human monocytes 
(Allam et al. 2011, Elliott and Sutterwala 2015, Holzinger et al. 2012, Karmakar et 
al. 2015, Kebaier et al. 2012, Ng et al. 2010, Walev et al. 1995). In addition, the well-
known mitochondrial respiratory chain inhibitor rotenone is also a known activator 
of this inflammasome (Zhou et al. 2011). Disruption of mitochondrial ion 
homeostasis by microbially produced ionophores could activate inflammasomes 
since, for example, calcium influx and potassium efflux have been shown to trigger 
activation and cytokine release (Elliott and Sutterwala 2015, Gurung et al. 2015, 
Muñoz-Planillo et al. 2013). 
Mitochondrial toxins with immunotoxic effects could play a role especially in the 
symptoms caused by exposure to toxins in indoor air, since individuals experiencing 
ill-health effects in moisture-damaged buildings most often display symptoms of 
inflammation, i.e., activation of innate immunity (IOM 2004). Exaggerated immune 
responses following from overstimulation of the innate immune system, 
overactivation of inflammasomes, and consequent unrestrained release of cytokines 
can lead to a so-called cytokine storm, which has been shown to have devastating 
effects on the body (Clark 2007). For example, a cytokine storm in the lungs can lead 
to acute lung injury and continue to spread to other organs via a spillover effect 
through blood circulation, leading to tissue damage and possibly sepsis (Tisoncik et 
al. 2012). It is worth noting that there appears to be quite a lot of variability in the 
innate immune responses of individuals, bringing about differences in susceptibility 
to cytokine storms (Tisoncik et al. 2012). It is commonly known that in many cases 
of both food poisoning and symptoms following exposure to moisture-damaged 
indoor spaces, individuals exposed to the same causative factor react differently, 
making it difficult to find conclusive evidence of causal relationships. 
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1.6. Methods for the detection of mitochondrial toxins 
In recent years, legislative pressure to avoid unnecessary animal testing in the 
European Union has highlighted the importance of developing reliable in vitro 
methods (ECHA 2014). A wide range of in vitro methods for detecting substances 
which affect mitochondrial functions have been developed, but none have as yet been 
standardized. Thus it is not possible to compare, for example, the sensitivities of the 
different methods on a general level. Examples of used bioassays are compiled in 
Table 3. 
The bioassays presented in Table 3 can be used in two ways: to determine the 
mitochondriotoxic effects of known substances (e.g., mitochondrial toxicity testing 
as part of drug development) and to detect mitochondrial toxicity in samples of 
unknown chemical composition (i.e., searching for novel mitochondriotoxins). In the 
latter case, chemical analysis, such as high-performance liquid chromatography 
combined with mass spectrometry (HPLC-MS), is required for the purification and 
identification of the toxic substance(s). Figure 4 presents a simplified schematic 
diagram of the process which can be used to find and identify novel mitochondrial 
toxins. Chemical analyses can also be used to search for specific mitochondrial toxins 
within a sample of unknown composition if the chemical characteristics and structure 
of the toxins are known. 
 
 
Figure 4. Simplified schematic diagram depicting the process of finding and 
identifying novel mitochondrial toxins. 
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1.6.1. Boar spermatozoa as indicators of mitochondrial toxicity 
Boar spermatozoa are efficient as indicators of mitochondrial toxicity (Ajao et al. 
2015, Hoornstra et al. 2003, Jääskeläinen et al. 2003, Vicente-Carrillo et al. 2015) 
and can be used to detect toxicity in food samples, such as rice and pasta, at 
concentrations relevant for human toxicity (Andersson et al. 1998a, Jääskeläinen et 
al. 2003). Boar spermatozoa are a close analogue to human sperm in many ways: e.g., 
they possess the sperm-specific Ca2+ channel CatSper (Vicente-Carrillo et al. 2014) 
which in human sperm is known to be activated by endocrine disrupting chemicals, 
causing elevated intracellular Ca2+ levels (Schiffer et al. 2014) which lead to 
mitochondrial dysfunction (Pandya et al. 2013). Substances toxic to boar 
spermatozoa can therefore be assumed to be toxic to human spermatozoa as well. For 
example, human cells and boar spermatozoa have been shown to be equally sensitive 
to cereulide (Jääskeläinen et al. 2003). 
Boar semen is of higher and more consistent quality than human semen (Vicente-
Carrillo et al. 2015) and more sensitive than e.g. bull semen (Jääskeläinen et al. 2003). 
It can be easily obtained from artificial insemination stations at low cost and in an 
animal-friendly manner. Boar spermatozoa can be especially useful for rapid toxicity 
screening of large sample amounts, as they enable the simultaneous detection of both 
loss of mitochondrial oxidative phosphorylation (indicated by loss of motility) and 
changes in the state of the mitochondrial membrane potential (using membrane 
potential sensitive dyes such as JC-1) (Hoornstra et al. 2003). Recent work by 
Vicente-Carrillo et al. (2015) showed that this combined type of analysis using boar 
spermatozoa paralleled the conventional test with human hepatoma cell line HepG2, 
often used in the pharmaceutical industry for in vitro screening of drugs, in detecting 
compounds causing human liver toxicity. However, the boar sperm assay gave results 
much faster than the HepG2 test (within 30 min vs. after 24 to 48 h), indicating that 
the boar sperm assay could be more user friendly (Vicente-Carrillo et al. 2015). 
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2. Aims of the study 
The purpose of this work was to investigate the types and prevalence of mitochondrial 
toxins produced by microbes in indoor air of moisture-damaged buildings as well as 
food and study the effects of these toxins on mammalian cells to gain insight into the 
possible consequences of long-term human exposure to sublethal concentrations. The 
hypothesis was that exposure to mitochondrial toxins via various routes could be 
more common than previously thought and this continued exposure to sub-acute 
toxicity may have long-term harmful health effects. 
Specific aims were to: 
1. develop methods for the collection of toxic aerosols in indoor air and test the 
suitability of the boar sperm motility assay for assessing aerosol toxicity 
(Paper I), 
2. specify the effects of the bacterial toxin amylosin, produced by bacteria 
isolated from both indoor air and food, on mammalian cells and mitochondria 
(Paper III), and 
3. uncover the cause(s) of observed toxicity in grain samples collected by the 
Finnish Food Safety Authority EVIRA (Papers II and IV).  
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3. Materials and methods 
All used materials and methods are described in the original papers (I-IV) which this 
thesis is based upon. Used methods are listed in Table 4. Used microbial strains are 
presented in Table 5 and used mammalian cell types in Table 6. 
Table 4. List of methods used in Papers I-IV. 
Method Paper 
Sampling 
Collection of indoor aerosols and dust I 
Isolation of bacterial strains 
Isolation from indoor dust I 
Isolation from grains II, IV 
Microscopy 
Light microscopy I, II, IV 
Fluorescence microscopy II, III, IV 
Detection of airborne compounds 
Flow-through chamber test I 
Conway chamber test I 
Analysis of chemical elements  
Inductively coupled plasma mass spectrometry (ICP-MS) I 
Investigation of conditions for toxin production 
Testing of cold tolerance of toxin production II 
Identification and characterization of bacterial strains 
Gram staining II 
Catalase and oxidase tests II 
Hydrolysis of starch II 
NaCl tolerance test II 
Penicillin susceptibility II 
Haemolysis test II 
Determination of growth temperature range  II 
Growth on varying media II 
Whole-cell fatty acid analysis II, IV 
16S rRNA gene sequencing (whole or partial) II, IV 
Whole-cell DNA fingerprinting by ribopattern analysis II, IV 
Bacillus cereus and cereulide-specific PCR assays II 
Characterization service of DSMZ I, IV 
Extraction of toxins 
Extraction from electrostatic filters, dust samples and building 
materials I 
Crude extraction from bacterial biomass II, IV 
Preparation of semipurified extracts from bacterial biomass I, II, III, IV 
Extraction from grains IV 
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Table 4. (cont.) 
Identification, quantification and purification of toxins 
High-performance liquid chromatography with UV detection 
(HPLC-UV) I, II, III 
Reversed-phase high-performance liquid chromatography (RP-
HPLC) I, II, III 
HPLC-electrospray ionization ion trap mass spectrometry 
(HPLC-ESI-IT-MS) I, II, III, IV 
Investigation of effects on mammalian cells 
Testing for toxicity in labware I 
Rapid boar sperm bioassay I, II, IV 
Boar sperm motility inhibition assay (BSMI assay) I, II, III, IV 
Detection of changes in membrane potential (∆Ψ) using the 
membrane potential responsive dye JC-1  II, III, IV 
Detection of changes in glucose consumption (glycolysis) II, IV 
Detection of metabolic acidosis II 
Detection of mitochondrial depolarization in intact cells II, IV 
Evaluation of effects on proliferating cells II 
Detection of cytokines using enzyme-linked immunosorbent 
assays (ELISA) III 
Detection of cytokines using Western blotting III 
Detection of cytokine mRNA transcription III 
Detection of necrotic cell death (resazurin reduction assay and 
triple staining with propidium iodide, calcein AM, and Hoechst 
33342) 
IV 
Measurement of potassium ion efflux from intact cells III 
Investigation of effects on microbial cells 
Assessment of growth inhibitory effects against bacteria and 
fungi III 
Investigation of effects on isolated rat liver mitochondria (RLM) 
Detection of mitochondrial swelling II 
Measurement of oxygen uptake II 
Measurement of membrane potential II 
Measurement of mitochondrial functions II 
Measurement of the kinetics of K+ influx into mitochondria II 
Investigation of effects on lipid membranes 
Black lipid membrane (BLM) method for measurement of 
ionophoricity  II 
  
29 
Ta
bl
e 
5.
 L
is
t o
f m
ic
ro
bi
al
 st
ra
in
s u
se
d 
in
 P
ap
er
s I
-I
V
. 
Pa
pe
r 
B
ac
te
ri
al
 st
ra
in
s 
I, 
II
, I
II
 
II
I I 
II
, I
II
 
II
 
II
, I
II
, 
IV
 
II
I 
R
ef
er
en
ce
 
M
ik
ko
la
 e
t a
l. 
20
04
 
un
pu
bl
is
he
d 
A
pe
tro
ai
e 
et
 a
l. 
20
05
 
H
äg
gb
lo
m
 e
t a
l. 
20
02
, T
ur
nb
ul
l 
et
 a
l. 
19
79
 
Fr
an
kl
an
d 
an
d 
Fr
an
kl
an
d 
18
87
 
H
al
la
ks
el
a 
et
 a
l. 
19
91
 
un
pu
bl
is
he
d 
R
ea
so
n 
fo
r u
se
 
Pr
od
uc
er
 o
f a
m
yl
os
in
 
C
om
pa
ris
on
 st
ra
in
 
(a
m
yl
os
in
 n
on
-p
ro
du
ce
r)
  
Pr
od
uc
er
 o
f c
er
eu
lid
e 
 
Pr
od
uc
er
 o
f c
er
eu
lid
e 
 
C
om
pa
ris
on
 st
ra
in
 
(c
er
eu
lid
e 
no
n-
pr
od
uc
er
) 
Pr
od
uc
er
 o
f c
er
eu
lid
e 
 
Ta
rg
et
 st
ra
in
 fo
r t
es
tin
g 
gr
ow
th
-in
hi
bi
tin
g 
pr
op
er
tie
s o
f a
m
yl
os
in
 
O
rig
in
 
In
su
la
tio
n 
m
at
er
ia
l o
f a
 re
si
de
nt
ia
l b
ui
ld
in
g 
in
 
Fi
nl
an
d 
w
ith
 m
oi
st
ur
e 
pr
ob
le
m
s  
So
ur
ce
 u
nk
no
w
n;
 o
bt
ai
ne
d 
fro
m
 IA
M
 C
ul
tu
re
 
C
ol
le
ct
io
n,
 T
ok
yo
, J
ap
an
 
In
do
or
 w
al
l o
f a
 h
os
pi
ta
l f
ac
ili
ty
 in
 F
in
la
nd
 
w
ith
 o
cc
up
an
ts
 c
om
pl
ai
ni
ng
 o
f b
ui
ld
in
g-
re
la
te
d 
ill
 h
ea
lth
 sy
m
pt
om
s 
C
oo
ke
d 
ric
e 
in
vo
lv
ed
 in
 a
 fo
od
 p
oi
so
ni
ng
 
in
ci
de
nt
, i
so
la
te
d 
in
 th
e 
U
K
 b
y 
th
e 
Pu
bl
ic
 
H
ea
lth
 L
ab
or
at
or
y 
Se
rv
ic
e 
A
ir 
in
 c
ow
 sh
ed
 
A
se
pt
ic
 c
or
e 
dr
ill
 sa
m
pl
e 
3.
5 
m
 fr
om
 u
p 
th
e 
tru
nk
 o
f a
 li
ve
 sp
ru
ce
 tr
ee
 (P
ic
ea
 a
bi
es
) i
n 
R
uo
ts
in
ky
lä
 re
se
ar
ch
 fo
re
st
 o
f t
he
 N
at
ur
al
 
R
es
ou
rc
es
 In
st
itu
te
 F
in
la
nd
 
W
at
er
-d
am
ag
ed
 p
ap
er
bo
ar
d 
fr
om
 a
 m
oi
st
ur
e-
da
m
ag
ed
 b
ui
ld
in
g 
Id
en
tif
ie
r(
s)
 
Ba
ci
llu
s 
am
yl
ol
iq
ue
fa
ci
en
s 
19
b 
(H
A
M
B
I 2
66
0)
 
B.
 a
m
yl
ol
iq
ue
fa
ci
en
s 
IA
M
 1
52
1 
(H
A
M
B
I 2
71
8)
 
Ba
ci
llu
s c
er
eu
s 7
/p
k4
 
(H
A
M
B
I 2
71
1)
 
B.
 c
er
eu
s F
48
10
/7
2 
(H
A
M
B
I 2
45
4)
 
B.
 c
er
eu
s A
TC
C
 
14
57
9T
 
B.
 c
er
eu
s N
S5
8 
(H
A
M
B
I 2
45
0)
 
Ba
ci
llu
s m
eg
at
er
iu
m
 
N
e1
0 
(D
SM
 1
76
41
) 
  
30 
Ta
bl
e 
5.
 (c
on
t.)
 
Pa
pe
r 
Ba
ct
er
ia
l s
tr
ai
ns
 
II
I 
II
I 
II
I I II II II 
R
ef
er
en
ce
 
un
pu
bl
is
he
d 
un
pu
bl
is
he
d 
A
nd
er
ss
on
 e
t a
l. 
19
97
, V
uo
rio
 e
t 
al
. 1
99
9 
 
no
ve
l i
so
la
te
 
no
ve
l i
so
la
te
 
no
ve
l i
so
la
te
 
N
el
so
n 
et
 a
l. 
20
09
 
R
ea
so
n 
fo
r u
se
 
Ta
rg
et
 st
ra
in
 fo
r t
es
tin
g 
gr
ow
th
-in
hi
bi
tin
g 
pr
op
er
tie
s o
f a
m
yl
os
in
 
Ta
rg
et
 st
ra
in
 fo
r t
es
tin
g 
gr
ow
th
-in
hi
bi
tin
g 
pr
op
er
tie
s o
f a
m
yl
os
in
 
Ta
rg
et
 st
ra
in
 fo
r t
es
tin
g 
gr
ow
th
-in
hi
bi
tin
g 
pr
op
er
tie
s o
f a
m
yl
os
in
 
To
xi
c 
to
 b
oa
r 
sp
er
m
at
oz
oa
 (c
au
se
 o
f 
to
xi
ci
ty
 u
nk
no
w
n)
 
Pr
od
uc
er
 o
f p
ae
ni
lid
e 
 
Pr
od
uc
er
 o
f p
ae
ni
lid
e 
C
om
pa
ris
on
 st
ra
in
 
(p
ae
ni
lid
e 
no
n-
pr
od
uc
er
) 
O
rig
in
 
H
ay
 d
us
t 
W
at
er
-d
am
ag
ed
 b
ui
ld
in
g 
m
at
er
ia
l o
f a
 2
1-
ye
ar
- 
ol
d 
ch
ild
re
n᾿
s d
ay
ca
re
 c
en
te
r i
n 
so
ut
he
rn
 F
in
la
nd
 
w
ith
 a
 h
is
to
ry
 o
f r
ep
ea
te
d 
w
at
er
 d
am
ag
e 
an
d 
cl
as
si
fie
d 
as
 a
 m
oi
st
ur
e 
pr
ob
le
m
 b
ui
ld
in
g 
by
  
he
al
th
 a
ut
ho
rit
ie
s 
Sa
m
e 
as
 D
ie
tzi
a 
sp
. M
A
14
7 
D
us
t c
ol
le
ct
ed
 fr
om
 th
e 
in
si
de
 o
f a
 c
om
pu
te
r i
n 
a 
ta
xi
 st
at
io
n 
of
fic
e 
in
 K
an
ka
an
pä
ä,
 F
in
la
nd
, w
ith
 
oc
cu
pa
nt
-r
ep
or
te
d 
bu
ild
in
g-
re
la
te
d 
ill
 h
ea
lth
 
sy
m
pt
om
s 
W
ho
le
 b
ar
le
y 
gr
ai
ns
 (c
ul
tiv
ar
 S
aa
na
) f
ro
m
 c
ro
p 
se
as
on
 2
00
1 
cu
lti
va
te
d 
in
 S
ou
th
er
n 
Fi
nl
an
d 
Sa
m
e 
as
 P
. t
un
dr
ae
 E
8a
 
A
rc
tic
 tu
nd
ra
 so
il 
Id
en
tif
ie
r(
s)
 
Ba
ci
llu
s s
p.
 O
S1
6 
D
ie
tzi
a 
sp
. M
A
14
7 
(H
A
M
B
I 3
59
5)
 
M
yc
ob
ac
te
riu
m
 
m
ur
al
e 
M
A
11
3 
(D
SM
 4
43
40
T )
 
Pa
en
ib
ac
ill
us
 
po
ly
m
yx
a 
R
S1
0 
(H
A
M
B
I 3
10
3)
 
Pa
en
ib
ac
ill
us
 
tu
nd
ra
e 
E8
a 
(H
A
M
B
I 3
23
2)
 
P.
 tu
nd
ra
e 
E8
b 
P.
 tu
nd
ra
e 
 
  
31 
Ta
bl
e 
5.
 (c
on
t.)
 
Pa
pe
r 
B
ac
te
ri
al
 st
ra
in
s 
I IV
 
II
I 
Fu
ng
al
 st
ra
in
s 
I I III
 
R
ef
er
en
ce
 
no
ve
l i
so
la
te
 
no
ve
l i
so
la
te
s 
A
nd
er
ss
on
 e
t 
al
. 1
99
7,
 
K
äm
pf
er
 e
t a
l. 
19
99
 
no
ve
l i
so
la
te
, 
id
en
tif
ic
at
io
n 
by
 M
ik
ko
la
 e
t 
al
. 2
01
5 
no
ve
l i
so
la
te
, 
id
en
tif
ic
at
io
n 
by
 M
ik
ko
la
 e
t 
al
. 2
01
5 
un
pu
bl
is
he
d 
R
ea
so
n 
fo
r u
se
 
Pr
od
uc
er
 o
f v
al
in
om
yc
in
 
Pr
od
uc
er
s o
f a
nt
im
yc
in
 A
 
an
d 
ot
he
r s
ub
st
an
ce
s 
to
xi
c 
to
 b
oa
r s
pe
rm
at
oz
oa
 
Ta
rg
et
 st
ra
in
 fo
r t
es
tin
g 
gr
ow
th
-in
hi
bi
tin
g 
pr
op
er
tie
s o
f a
m
yl
os
in
 
Pr
od
uc
er
 o
f s
te
ph
ac
id
in
 B
 
an
d 
av
ra
in
vi
lla
m
id
e 
Pr
od
uc
er
 o
f s
te
ph
ac
id
in
 B
 
an
d 
av
ra
in
vi
lla
m
id
e 
Ta
rg
et
 st
ra
in
 fo
r t
es
tin
g 
gr
ow
th
-in
hi
bi
tin
g 
pr
op
er
tie
s o
f a
m
yl
os
in
 
O
rig
in
 
C
om
m
er
ci
al
 b
ak
er
y 
in
 F
in
la
nd
 w
ith
 w
or
ke
rs
 
su
ff
er
in
g 
fr
om
 b
ui
ld
in
g -
re
la
te
d 
ill
 h
ea
lth
 
sy
m
pt
om
s 
W
ho
le
 sp
rin
g 
w
he
at
 g
ra
in
s a
nd
 w
ho
le
 b
ar
le
y 
gr
ai
ns
 fr
om
 c
ro
p 
se
as
on
s 2
00
1 
an
d 
20
02
 c
ul
tiv
at
ed
 
in
 S
ou
th
er
n 
an
d 
W
es
te
rn
 F
in
la
nd
 
N
on
-w
at
er
-d
am
ag
ed
 g
yp
su
m
 w
al
l l
in
er
 o
f a
 
sl
ee
pi
ng
 ro
om
 in
 a
 2
1-
ye
ar
-o
ld
 c
hi
ld
re
n᾿
s d
ay
ca
re
 
ce
nt
er
 in
 so
ut
he
rn
 F
in
la
nd
 w
ith
 a
 h
is
to
ry
 o
f 
re
pe
at
ed
 w
at
er
 d
am
ag
e 
an
d 
cl
as
si
fie
d 
as
 a
 m
oi
st
ur
e 
pr
ob
le
m
 b
ui
ld
in
g 
by
 h
ea
lth
 a
ut
ho
rit
ie
s 
D
us
t c
ol
le
ct
ed
 o
ve
r 3
.5
 m
on
th
s f
ro
m
 th
e 
fin
e-
du
st
 
fil
te
r o
f t
he
 sh
ar
ed
 c
en
tra
l v
ac
uu
m
 c
le
an
er
 o
f a
 
te
rr
ac
ed
 tw
o-
fa
m
ily
 h
ou
se
 in
 L
oh
ja
, F
in
la
nd
 w
ith
 
re
po
rte
d 
bu
ild
in
g -
re
la
te
d 
ill
 h
ea
lth
 sy
m
pt
om
s 
A
er
os
ol
 c
ol
le
ct
ed
 b
y 
el
ec
tro
fil
tra
tio
n 
fr
om
 a
 
ki
nd
er
ga
rte
n 
in
 T
am
pe
re
, F
in
la
nd
, w
ith
 o
cc
up
an
t-
re
po
rte
d 
bu
ild
in
g-
re
la
te
d 
ill
 h
ea
lth
 sy
m
pt
om
s 
M
ic
ro
bi
al
ly
 d
am
ag
ed
 in
do
or
 b
ui
ld
in
g 
en
vi
ro
nm
en
t 
in
vo
lv
ed
 in
 a
 fa
ta
l h
um
an
 c
as
e 
Id
en
tif
ie
r(
s)
 
St
re
pt
om
yc
es
 
gr
ise
us
 1
0/
pp
i 
(D
SM
 4
17
51
) 
St
re
pt
om
yc
es
 sp
. 
(1
8 
is
ol
at
es
) 
W
ill
ia
m
sia
 m
ur
al
is
 
14
0/
96
 (D
SM
 
44
34
3T
) 
As
pe
rg
ill
us
 
w
es
te
rd
ijk
ia
e 
pp
2 
(H
A
M
B
I 3
33
3)
 
As
pe
rg
ill
us
 
w
es
te
rd
ijk
ia
e 
K
aI
II
 
(H
A
M
B
I 3
33
5)
 
C
ha
et
om
iu
m
 
gl
ob
os
um
 M
TA
V
35
 
(H
A
M
B
I 3
33
6)
 
  
32 
Ta
bl
e 
6.
 L
is
t o
f m
am
m
al
ia
n 
ce
lls
 u
se
d 
in
 P
ap
er
s I
-I
V
. 
Pa
pe
r 
II
I 
II
I 
II
I II
 
I, 
II
, I
II
, I
V
 
II
, I
V
 
N
/A
 =
 N
ot
 a
pp
lic
ab
le
 
R
ef
er
en
ce
 
B
ou
ka
m
p 
et
 a
l. 
19
88
 
N/
A 
N/
A 
N/
A 
N/
A 
Ec
ha
rd
 1
97
4 
So
ur
ce
 
H
aa
rtm
an
 In
st
itu
te
, H
el
si
nk
i, 
Fi
nl
an
d 
D
iff
er
en
tia
te
d 
fr
om
 m
on
oc
yt
es
 is
ol
at
ed
 
fr
om
 h
um
an
 b
uf
fy
 c
oa
ts
 fr
om
 F
in
ni
sh
 
R
ed
 B
lo
od
 S
er
vi
ce
, H
el
si
nk
i, 
Fi
nl
an
d 
Is
ol
at
ed
 fr
om
 h
um
an
 b
uf
fy
 c
oa
ts
 fr
om
 
Fi
nn
is
h 
R
ed
 B
lo
od
 S
er
vi
ce
, H
el
si
nk
i, 
Fi
nl
an
d 
Fi
nn
is
h 
Fo
od
 S
af
et
y 
A
ut
ho
rit
y 
EV
IR
A
, 
H
el
si
nk
i, 
Fi
nl
an
d 
Fi
ge
n 
O
y,
 T
uo
m
ik
yl
ä,
 F
in
la
nd
 
Fi
nn
is
h 
Fo
od
 S
af
et
y 
A
ut
ho
rit
y 
EV
IR
A
, 
H
el
si
nk
i, 
Fi
nl
an
d 
A
bb
re
vi
at
io
n 
or
 c
el
l l
in
e 
co
de
 
H
aC
aT
 
N/
A 
PB
M
C
 
M
N
A
 
N/
A 
PK
-1
5 
C
el
l t
yp
e 
H
um
an
 k
er
at
in
oc
yt
es
 
Pr
im
ar
y 
hu
m
an
 
m
ac
ro
ph
ag
es
 
H
um
an
 p
rim
ar
y 
pe
rip
he
ra
l b
lo
od
 
m
on
on
uc
le
ar
 c
el
ls 
M
ur
in
e 
ne
ur
ob
la
st
om
a 
ce
lls
 
Po
rc
in
e 
sp
er
m
at
oz
oa
 
Po
rc
in
e 
ki
dn
ey
 tu
bu
la
r 
ep
ith
el
ia
l c
el
ls
 
33 
4. Results and discussion 
This work consisted of two parts, one focusing on microbially produced toxic 
compounds found in moisture-damaged buildings and their effects on mammalian 
cells and the other aimed at determining novel food safety risks related to toxin-
producing bacteria in stored grains. Papers I and III present research related to the 
first focus area, covering methods useful for the collection and toxicity assessment of 
indoor air aerosols and investigating the effects of the indoor air toxin amylosin on 
mammalian cells. Papers II and IV report on two studies related to previously 
unknown or underestimated food safety hazards: the discovery of a completely new 
peptide toxin produced by Paenibacillus tundrae isolated from barley grains and the 
finding of toxin-producing Streptomyces strains in barley and wheat grains. 
4.1. Toxic compounds in moisture-damaged buildings 
The work presented in Papers I and III concerns mitochondrial toxins in moisture-
damaged indoor environments. Paper I focuses on method development including the 
BSMI assay, which was also used in all other Papers connected to this thesis work. 
Paper III presents a more detailed investigation into the effects of the indoor air toxin 
amylosin on mammalians and microbial cells. 
4.1.1. Toxicity of indoor dusts and aerosols 
Paper I describes and evaluates three different methods for the collection of indoor 
dusts and aerosols for toxicity testing: wiping and swabbing settled dust from 
surfaces, collecting dust from vacuum cleaners filters and dust bags, and electrostatic 
filtration. Using the inhibition of boar spermatozoa motility (BSMI assay) as an 
indicator, toxicity was found in samples collected from moisture-damaged indoor 
spaces with all three methods (Table 2 in Paper I). Aerosols collected by 
electrofiltration contained on average six times more ethanol/methanol soluble 
compounds than dusts collected by other means (Table 2 in Paper I), indicating that 
the electrostatic filters were efficient at collecting lipid-containing aerosolized 
substances. 
The toxicity of the collected dusts and aerosols detected using the BSMI assay was 
clearly higher in samples from indoor environments where occupants reported ill 
health symptoms (Table 2 in Paper I and Figure 5). Although the sample size of the 
study was not sufficient for reliable statistical analysis, it would appear that there was 
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a possible correlation between the ill health complaints and toxicity detected using 
the BSMI assay. 
 
Figure 5. Range of toxicity of dust and aerosol samples detected using the BSMI 
assay. Toxicity is expressed as EC50 values, indicating the amount of ethanol or 
methanol-soluble compounds as μg per mg−1 of dust or of aerosol required for 
inhibiting the motility of >50% of the boar sperm cells within 4 d compared to vehicle 
control. Figure shows average (■) as well as range (vertical lines) for each sample 
group. Settled dust from a hay storage barn (accumulated over a period of >3 years) 
and substances from an unused electrostatic filter were used as reference samples. 
The figure is based on data presented in Table 2 of Paper I. 
 
Of the collected dust and aerosol samples, 16 were cultured (13 from sites with 
reported health complaints and 3 from sites with no reported health complaints). 
Mixed microbial cultures obtained from 12 of the collected dust samples from sites 
with reported health complaints had EC50 values of <30 μg mg−1 within one day of 
exposure in the BSMI assay, indicating toxicity (Table 3 in Paper I). A total of 42 
isolates obtained from these mixed cultures showed toxicity in the BSMI assay. As 
presented in Paper I, 11 of these isolates were identified as Aspergillus westerdijkiae 
(identification reported by Mikkola et al. 2015), Bacillus amyloliquefaciens, Bacillus 
cereus, Bacillus simplex, Bacillus subtilis, Paenibacillus polymyxa, and Streptomyces 
griseus. 
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All of these taxons have been previously reported from moisture-damaged indoor 
environments. Aspergillus is one of the most commonly found fungal genera in damp 
indoor spaces and building materials (Andersson et al. 1997, Heseltine et al. 2009, 
Verdier et al. 2014) as well as indoor dust (Rintala et al. 2012). Aspergillus species 
have also been linked to mycotoxins present in building materials (Tuomi et al. 2000). 
Bacillus species including B. cereus, B. subtilis and B. amyloliquefaciens have been 
reported to be common in dust and air in moisture-damaged buildings (Andersson et 
al. 1999), and toxin-producing B. amyloliquefaciens strains have been isolated from 
dust and insulation materials of moisture-damaged sites (Mikkola et al. 2004). P. 
polymyxa has been found in building materials in moisture-damaged buildings 
(Andersson et al. 1997). S. griseus and other Streptomyces spp. have been isolated 
from building materials (Andersson et al. 1997, Andersson et al. 1999) and settled 
dust (Andersson et al. 1998b) in moisture-damaged buildings. Overall, it has been 
suggested that the presence of Streptomyces in indoor spaces could indicate dampness 
and moisture damage (Rintala et al. 2004). 
Four toxins were identified from the pure cultures which were toxic in the BSMI 
assay: amylosin (from B. subtilis), cereulide (from B. cereus), valinomycin (from S. 
griseus), and stephacidin B (from two strains of Aspergillus westerdijkiae). These 
compounds had a toxic effect at very low concentrations (EC50 values of ≤0.2 μg ml−1 
after 3 to 4 day exposure) in the BSMI assay (Table 4 in Paper I). Amylosin, 
cereulide, and valinomycin collapse the potassium homeostasis of cells and 
mitochondria (Mikkola et al. 2007, Teplova et al. 2006), whereas the toxicity of 
stephacidin B is not due to a direct effect on mitochondria (Mikkola et al. 2015) but 
instead possibly linked to it binding to cysteine residues in proteins (Wulff et al. 
2007), such as the cysteine-rich protein which affects the motility of spermatozoa 
(Hawthorne et al. 2006). Despite this difference in the mechanism of toxicity, these 
four toxins, and other toxic substances not yet identified, were detected by the BSMI 
assay, and could explain at least a part of the overall toxicity towards boar 
spermatozoa observed in the dust the aerosol samples. 
Amylosin was first detected from B. amyloliquefaciens strains isolated from 
moisture-damaged buildings (Mikkola et al. 2004). Producers of amylosin, most 
closely affiliated with B. subtilis group species (Apetroaie-Constantin et al. 2009, 
Mikkola et al. 2004), as well as producers of cereulide, which belong to a specific 
subgroup of B. cereus (Agata et al. 1996, Ehling-Schulz et al. 2005), are both 
common in sick buildings (Andersson et al. 2005) and are also connected with food 
poisoning (Apetroaie-Constantin et al. 2009, Rajkovic 2014). Producers of 
valinomycin representing different species of Streptomyces were also previously 
reported in moisture-damaged buildings (Andersson et al. 1998b, Andersson et al. 
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2005, Täubel et al. 2011). Stephacidin B, however, has previously been reported only 
from an Aspergillus ochraceus strain isolated from clay in India (Qian-Cutrone et al. 
2002). It is interesting that a producer of stephacidin B was found in two separate 
sampling sites (see Table 5 in this thesis), indicating the possibility that it might be 
present more commonly in “sick buildings”, since species of Aspergillus are 
considered common contaminants of moisture-damaged sites (Heseltine et al. 2009). 
4.1.2. Detecting indoor aerosolization and transfer of toxic 
compounds 
Two methods for detecting the aerosolization of toxic compounds were examined in 
Paper I. Using a stainless steel flowthrough chamber, it was shown that measurable 
amounts of valinomycin, produced by a strain of Streptomyces griseus, was 
transferred via air to the stainless steel walls and the glass fiber exit valve filter of the 
chamber (Table 5 in Paper I). The transfer of valinomycin was detected by LC-MS 
analysis and the transfer of toxicity was confirmed using the BSMI assay. In addition, 
a Conway chamber was used to study toxic compounds emitted into the air from 
building materials. Boar spermatozoa motility was used to detect the transfer of 
toxicity via air (Table 6 in Paper I). Both approaches showed that boar spermatozoa 
can be used as indicators of aerosolized compounds toxic to mammalian cells. 
The samples collected by electrofiltration (Table 1 in Paper I) contained a higher 
amount of lipophilic material compared to settled dust samples, indicating that 
vehicles other than dust can carry hydrophobic compounds in air. Recently, 
hydrophobic toxins such as communesins and chaetoglobosin were shown to be 
carried by water vapor (Salo et al. 2015). This is explained by the air-side of the air-
water interface of water nanodroplets present in air which is very hydrophobic, 
suggesting that these droplets would attract non-polar compounds and could act as 
carriers (van Oss et al. 2005). The log KOW of valinomycin is 4.49 (Teplova et al. 
2006), indicating that it is a highly hydrophobic compound. Since acid proof stainless 
steel is a hydrophobic surface (Raulio et al. 2008), airborne water nanodroplets could 
be the vehicle which transferred valinomycin to the steel surfaces of the test chamber 
via air (Table 5 in Paper I). This type of transfer could explain why renovation of 
moisture-damaged buildings does not always lead to the disappearance of ill health 
symptoms in occupants (Rudblad et al. 2002, Sauni et al. 2015): toxic substances 
causing the symptoms may be transferred back into the building along with furniture 
and other items which could have “collected” hydrophobic toxic compounds in the 
moisture-damaged interiors prior to repair. There are no published reports 
definitively demonstrating this type of transfer, but official published guidelines and 
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expert recommendations for the remediation of moisture-damaged indoor spaces 
state that it is often necessary to dispose of all dispensable items which have been 
exposed to the moisture-damaged space, as these items may cause a renewal of 
symptoms (Anon. 2011, Kärki and Öhman 2007). Overall, it has been stated that the 
effects of remediation of moisture-damaged buildings have not been studied 
sufficiently (Tischer and Heinrich 2013). 
4.1.3. BSMI assay as a detector of toxicity 
The results of the work presented in Paper I showed that the BSMI assay is useful as 
a method for detecting potential airborne toxicity and toxigenic microbes in indoor 
environments of moisture-damaged buildings. This method has previously been 
shown to be effective for detecting toxin-producing microbes and toxicity in 
moisture-damaged buildings and building materials from such sites (Andersson et al. 
1997, Andersson et al. 1998b, Andersson et al. 2009, Mikkola et al. 2004, Peltola et 
al. 2004). However, the subjectivity of the assay readout, the unknown composition 
of the mixed toxic chemical load of indoor dusts, and the sometimes modest 
differences in the EC50 values of dusts from damaged vs. non-damaged buildings 
hampers the use of this method for comparing toxicities in buildings where 
inhabitants are exposed to unhealthy indoor air. Refinement of the assay as well as 
development of more representative sampling is still needed, but overall the method 
shows promise and could be used as a preliminary screening method in the search for 
indoor air toxicity. 
In our work with boar spermatozoa, it was noted that there is a risk of false positive 
results due to toxicity leaching from plastic laboratory disposables, such as test tubes 
and centrifuge tubes as well as latex and vinyl gloves, into the vehicle substance (e.g. 
ethanol or methanol) (Paper I). Toxicity testing of laboratory disposables and media 
using human sperm for detecting embryonic toxicity is a common method of quality 
control used in in vitro fertilization laboratories (Claassens et al. 2000, Lierman et al. 
2007). For example, the human sperm motility assay has been used to detect toxicity 
in gloves (Lierman et al. 2007) as well as syringes, filters and blood collection tubes 
(Claassens et al. 2000) used for in vitro fertilization. The results in Paper I highlight 
the importance of control samples and overall experiment quality control necessary 
in toxicity testing. 
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4.1.4. Effects of amylosin on mammalian and microbial cells 
Results presented in Paper III show that amylosin, a heat-stable channel-forming 
toxin first identified from strains of Bacillus amyloliquefaciens isolated from 
moisture-damaged indoor spaces (Mikkola et al. 2004, Mikkola et al. 2007), had 
immunotoxic and potassium efflux-inducing effects on mammalian cells. Amylosin 
and its producer strain also displayed antagonistic effects on microbes. 
4.1.4.1. Immunotoxic effects 
The results in Paper III showed for the first time that amylosin stimulated the 
secretion of inflammatory cytokines IL-1β and IL-18 from LPS-primed human 
macrophages both in a biomass extract of strain B. amyloliquefaciens 19b (amylosin 
producer) and as a purified substance (Fig. 1 and 4 in Paper III). Upregulation of 
cytokine mRNA transcription and high levels (>2,000 pg ml-1) of active cytokine 
secretion were induced within 2 h of exposure to nanomolar concentrations (50 ng 
ml-1) of amylosin (Fig. 2 in Paper III). 
This is the first report of a bacterial channel-forming ionophore toxin stimulating 
cytokine release from human primary macrophages. Other bacterial toxins reported 
to induce IL-1β and/or IL-18 secretion include nigericin from Streptomyces 
hygroscopicus, hemolysin and multifunctional repeat-in-toxin from Vibrio cholerae 
and V. vulnificus, cytolethal distending toxin from Aggregatibacter 
actinomycetemcomitans, community-acquired respiratory distress syndrome toxin 
from Mycoplasma pneumoniae, β-hemolysin from Streptococcus agalactiae, Panton-
Valentine leucocidin and α-hemolysin from Staphylococcus aureus, TcdA and TcdB 
toxins from Clostridium difficile, antrax lethal toxin from Bacillus anthracis, 
gramicidin from Brevibacillus brevis, and valinomycin from Streptomyces spp. (Bose 
et al. 2014, Cordoba-Rodriguez et al. 2004, Gupta et al. 2014, Holzinger et al. 2012, 
Kebaier et al. 2012, Mariathasan et al. 2006, Ng et al. 2010, Shenker et al. 2015, 
Toma et al. 2010, Walev et al. 1995). In addition, the trichothecene mycotoxins 
roridin A, verrucarin A, and T-2 toxin have been shown to activate IL-1β and IL-18 
secretion from human primary macrophages (Kankkunen et al. 2009). It is difficult 
to compare the results of these reports to the results presented in Paper III, as the used 
methods (e.g., varying exposure times, culture conditions, cell densities) and cell 
types (e.g., murine macrophage and human monocytic leukemia cell lines vs. human 
primary macrophages) are not standardized and most published results have not been 
obtained with pure substances. However, it can be seen that the amount of IL-1β (up 
to >30,000 pg ml-1 within 18 h) released by macrophages exposed to nanomolar 
concentrations of amylosin is higher than the IL-1β release induced by other toxins 
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(varying from 40 to 13,000 pg ml-1) (Bose et al. 2014, Cordoba-Rodriguez et al. 2004, 
Gupta et al. 2014, Holzinger et al. 2012, Kankkunen et al. 2009, Kebaier et al. 2012, 
Mariathasan et al. 2006, Ng et al. 2010, Shenker et al. 2015, Toma et al. 2010), 
indicating that amylosin is a highly potent activator of the NLRP3 inflammasome. 
It is generally accepted that symptoms experienced by inhabitants of moisture-
damaged buildings, such as asthma and other disorders linked to immune reactions, 
are caused by exposure to microbes, microbial cell components, and compounds 
produced by microbes, with the main exposure route being inhalation (Heseltine et 
al. 2009). The release of active inflammatory cytokines IL-1β and IL-18 following 
inflammasome activation caused by substances such as amylosin could well explain 
at least part of the wide variety of symptoms, as these cytokines participate in many 
ways in both local and systemic inflammation (Dinarello 2009). The link between 
inflammasome activation and pulmonary diseases appears especially strong, since 
chronic inflammation is considered a characteristic feature of these disorders 
(Hosseinian et al. 2015). Amylosin is a moderately lipophilic compound with a log 
KOW between 3 and 4 (Mikkola 2006), so it is plausible that it could be aerosolized 
similarly as valinomycin (Paper I), dispersed via water vapor as has been reported for 
fungal toxins (Salo et al. 2015), and inhaled by inhabitants of indoor spaces 
contaminated by amylosin-producing bacteria. On coming into contact with alveolar 
macrophages, the inhaled amylosin could induce inflammasome activation and 
subsequent cytokine release, causing inflammation-type reactions such as asthma-
related symptoms, which are reportedly more common among occupants of moisture-
damaged indoor environments than the general population (Fisk et al. 2007, Mendell 
et al. 2011, Mudarri and Fisk 2007, Piipari and Keskinen 2005). A similar hypothesis 
has previously been presented in relation to trichothecene mycotoxins produced by 
Stachybotrys chartarum, a known contaminant of water-damaged buildings 
(Kankkunen et al. 2009). 
4.1.4.2. Toxin-induced efflux of potassium ions 
Exposure to low concentrations (≤5 μg ml−1) of purified amylosin caused significant 
dose-dependent potassium ion efflux from the cytoplasm of human somatic cells and 
porcine spermatozoa to the extracellular fluid within minutes (Fig. 5 in Paper III). 
Intact human primary PBMC and human cultured keratinocytes (HaCaT), both 
suspended in a potassium-free medium at 24 °C, released 40% and 1%, respectively, 
of intracellular K+ within 15 min of exposure to 5 μg ml−1 (PBMC) or 3.2 μg ml−1 
(HaCaT cells) of amylosin. In the same exposure conditions, the intracellular K+ 
stores of porcine spermatozoa (90 nmol per 54 × 106 sperm cells, i.e., circa 1.7 fmol 
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per sperm cell) were completely depleted within 5 minutes of exposure to 0.5 μg 
amylosin ml−1, which corresponds with approximately 25 K+ ions passing through 
the cell membrane per molecule of amylosin per minute at a concentration of 5 × 106 
molecules of amylosin per sperm cell. The efflux of potassium ions led to the 
depolarization of both the cytoplasmic membrane and the mitochondrial membranes 
in human keratinocytes (Fig. 6 in Paper III) and PBMC cells. 
It has been suggested that the NLRP3 inflammasome is activated not by specific 
foreign molecules acting as danger signals but rather by generic stress signals 
produced by cells being exposed to detrimental compounds (Abderrazak et al. 2015). 
One such generic activator is potassium efflux, which by itself has been shown to 
induce activation of NRLP3 in macrophages (Muñoz-Planillo et al. 2013) and 
neutrophils (Karmakar et al. 2015). In addition, prior to the recognition of the 
inflammasome in 2002 (Martinon et al. 2002), work published regarding the 
activation of IL-1β release following exposure of human primary monocytes to the 
potassium efflux-inducing bacterial toxins nigericin, gramicidin, and valinomycin 
highlighted the importance of potassium ion movement in cytokine release (Walev et 
al. 1995). The results presented in Paper III support this potassium efflux theory, 
since the toxicity of amylosin is based on its functioning as an illegitimate potassium 
channel. In addition, mitochondrial damage caused by exposure to amylosin may 
further increased NLRP3 activation, explaining the continued rise in levels of 
released cytokines over time after exposure to amylosin (Fig. 2 in Paper III). 
4.1.4.3. Antimicrobial activity 
When co-cultured on agar plates, the amylosin-producing B. amyloliquefaciens strain 
19b inhibited the growth of a toxigenic fungus, Chaetomium globosum MTAV35, 
and various gram-positive and gram-negative bacterial strains originating from 
moisture-damaged indoor environments (Fig. 7 in Paper III). In addition, purified 
amylosin inhibited the growth of a firmicute, B. megaterium Ne10, and an 
actinobacterium, Dietzia sp. MA147, in broth culture. Amylosin was 100-fold more 
potent as a growth inhibitor than the known bioactive lipopeptides produced by 
certain strains of B. amyloliquefaciens (fengycin, iturin, surfactin) or cereulide 
produced by B. cereus (Table 1 in Paper III). 
The observed antimicrobial effects of amylosin may explain why this compound is 
produced by B. amyloliquefaciens 19b, which also produces the biosurfactant 
surfactin and the antifungal compound fengycin (Mikkola 2006, Mikkola et al. 2007). 
The microbiota of indoor dusts in moisture-damaged buildings is diverse (Andersson 
et al. 1999, Nilsson et al. 2004, Peltola et al. 2001a, Rintala et al. 2008), making such 
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sites competitive environments. Thus, the ability to produce substances which can 
suppress the growth of other microbes may give the producer a competitive 
advantage. Strains producing amylosin could become dominant in moisture-damaged 
buildings offering suitable growth conditions and therefore pose a significant health 
risk for the occupants of such sites. 
4.2. Bacterial toxins causing novel food safety hazards 
in stored grains 
The grains samples studied in Papers II and IV, received from the Finnish Food Safety 
Authority EVIRA, were selected for the current study because they showed 
unexplained rapid toxicity in the BSMI assay (M. A. Andersson and M. Jestoi, 
unpublished results). The sampled grains contained mycotoxins, but the detected 
amounts of enniatins and beauvericin (Table 1 in Paper IV) did not explain the rapidly 
detected toxicity. Therefore, further investigation into the possible bacterial 
contaminants of the grains was conducted, which led to the finding of a novel 
bacterial toxin, paenilide, as well as the discovery of toxic Streptomyces strains 
producing antimycin A and unidentified toxin(s). 
4.2.1. Paenilide, a novel bacterial toxin 
Paenilide is a bacterial heat-stable depsipeptide toxin which acts as a potassium ion 
carrier similarl to cereulide. Paper II is the first report of this toxin. Due to its 
structural and mass spectral similarity to cereulide, paenilide could be considered a 
member of the growing family of cereulide isomers and congeners (Marxen et al. 
2015a). However, paenilide appears to be the first cereulide-like toxin produced by a 
species other than B. cereus sensu lato. 
The producers of paenilide were isolated from grains of barley (Figure 6) and 
identified as two strains of Paenibacillus tundrae based on 16S rRNA gene 
sequencing and biochemical characterization. Strain E8a produced larger amounts of 
paenilide than strain E8b. Cereulide has been shown to increase the survival of 
Bacillus cereus by acting as a potassium scavenger (Ekman et al. 2012). In a 
preliminary experiment examining the effect of cereulide on the growth rate of P. 
tundrae E8a conducted as described by Ekman et al. (2012), it appeared that the 
exponential growth phase of the paenilide-producer was delayed and ended at a lower 
cell density in a potassium-deficient medium, implying that the availability of 
potassium affected the growth of this strain (Ekman 2010 personal communication, 
unpublished results). When cereulide was added to the medium, the growth of the 
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paenilide-producer slowed regardless of the potassium concentration of the medium, 
indicating that cereulide is more effective as a potassium scavenger than paenilide. It 
has been suggested that cereulide may give its producers a competitive advantage in 
potassium-scarce environments (Ekman et al. 2012). The production of paenilide may 
offer its producer the same type of competitive advantage, albeit with lower 
efficiency.  
 
Figure 6. Grain of barley with Paenibacillus tundrae E8a growth on tryptic soy agar 
medium. 
Although the optimal growth temperature for most paenibacilli is 28 to 40 °C (Priest 
2009), some are psychrotolerant and can grow in pasteurized foods such as vegetable 
purées and milk at temperatures below 8 °C (Carlin et al. 2000, Fromm and Boor 
2004, Guinebretiere et al. 2001, Huck et al. 2008, Ivy et al. 2012, Masiello et al. 2014, 
Moreno Switt et al. 2014, Patterson et al. 2012, Ranieri et al. 2009, Ranieri et al. 
2012, Schmidt et al. 2012). The production of paenilide by strain P. tundrae E8a 
occurred at the same rate (20 to 50 ng of paenilide per mg of biomass wet wt) at 
temperatures varying from +5 °C to +28 °C. The strain also grew and produced 
paenilide at +37 °C, but the toxin yield appeard lower based on the results of the 
BSMI assay. Unlike cereulide-producing B. cereus (Delbrassinne et al. 2011, 
Häggblom et al. 2002, Thorsen et al. 2009), P. tundrae E8a produced paenilide also 
at cold temperatures and could, therefore, endanger the food safety of chilled foods. 
Paenibacilli have been reported from raw milk (Coorevits et al. 2008, De Jonghe et 
al. 2010, Huck et al. 2008, Ranieri et al. 2012) and many kinds of vegetables (Fangio 
et al. 2010). Viable paenibacilli have also been detected in ultra-high temperature 
(UHT) treated milk (Scheldeman et al. 2004) and raw milk heated up to temperatures 
of 130°C (te Giffel et al. 2002), indicating that Paenibacillus spores may match in 
thermal tolerance those of notoriously heat-resistant, cereulide-producing B. cereus 
(Carlin et al. 2006, Luu-Thi et al. 2014). 
Paenibacilli are also common in food-packaging paperboard (Pirttijärvi et al. 1996, 
Pirttijärvi 2000, Raaska et al. 2002, Suihko and Stackebrandt 2003, Suominen et al. 
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1997, Suominen et al. 2003, Väisänen et al. 1991), where they most likely end up due 
to their widespread presence as spores in soil and as endophytes in plants (Zeigler 
2013). Damage to the interior polyethylene coating of food packaging carton gives 
microbes access to moisture and nutrients, leading to microbial growth inside the 
paperboard (Suominen et al. 1997). Therefore, foodstuffs themselves, such as raw 
milk, as well as cardboard packaging, such as milk cartons, could both acts as sources 
of Paenibacillus contamination posing a food safety hazard for products with 
extended shelf lives, even in proper refrigerated storage conditions. Figure 7 
summarizes the possible routes through which paenibacilli could contaminate chilled 
foods. 
Extending the shelf life of chilled food products is of great interest in the global food 
market, and secondary antimicrobial metabolites of paenibacilli have been 
investigated as a method for improving the microbiological safety of foods (Gerst et 
al. 2015, Girardin et al. 2002, Piuri et al. 1998, Stern et al. 2005, Yang et al. 2013). 
However, based on the results presented in Paper II of this thesis, it appears that novel 
food safety hazards could be connected to both unintentional and intentional addition 
of paenibacilli to chilled processed foods with extended shelf lives. 
 
Figure 7. Potential routes through which Paenibacillus spp. could contaminate 
chilled foods. 
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4.2.1.1. Chemical characterization of paenilide 
Paenilide consists of two components, named paenilide and homopaenilide, which 
could be separated from each other by HPLC fractionation. The molecular masses of 
paenilide (1,152 Da) and homopaenilide (1,166 Da) were identical to those of 
cereulide (Mikkola et al. 1999, Pitchayawasin et al. 2004) and homocereulide 
(Pitchayawasin et al. 2004, Wang et al. 1995), respectively, indicating they might 
represent novel members of the rapidly extending chemodiversity of cereulide 
(Marxen et al. 2015a). However, the retention times of the paenilide compounds were 
longer (+4 min), indicating more hydrophobic structures than those of the cereulide 
compounds. The mass fragmentation patterns of paenilide and homopaenilide were 
also identical to those of cereulide and homocereulide, respectively, but the higher 
hydrophobicity of the paenilide compounds indicated that they might contain three 
(paenilide) or four (homopaenilide) 2-hydroxy-3-methylpentanoic acid residues (O-
Ile) instead of the three or four 2-hydroxyisocaproic acid residues (O-Leu) present in 
cereulide and homocereulide (Pitchayawasin et al. 2004), respectively. This structural 
difference implies that paenilide may be produced by synthetases encoded by genes 
independent of cereulide synthetases. This is supported by the fact that the paenilide-
producing strain P. tundrae E8a tested negative for the cereulide synthetase gene 
cesB (Paper II). 
Cereulide is of growing concern as a cause of food poisoning. Reports of the 
European Food Safety Authority (EFSA) show that the number of reported food-
borne outbreaks with Bacillus toxins as the causative agent increased by 190% from 
2010 to 2014 (99 outbreaks in 2010 vs. 287 outbreaks in 2013), while the total 
reported amount of outbreaks caused by bacterial toxins rose by 82% (461 outbreaks 
in 2010 vs. 840 outbreaks in 2014), with Bacillus toxins accounting for 34% of all 
bacterial toxin-related outbreaks in 2014 (EFSA and ECDC 2012, EFSA and ECDC 
2015). It is not reported whether this rise is indicative of truly higher incidence or a 
result of increased awareness and improved detection methods. However, cereulide-
producing strains of B. cereus have recently been shown to be more prevalent and 
present in more types of foods than previously assumed (Messelhausser et al. 2014). 
The detection and quantification of cereulide and cereulide-like compounds is thus 
of increasing importance. An ISO-EN standard for the quantitative analysis of 
cereulide in foods using LC-MS/MS (ISO/DIS 18465) is currently under 
development (status 30.12.2015; http://www.iso.org/iso/home/store/catalogue_tc/) 
and a method for the combined quantification of multiple cereulide variants has 
recently been developed (Marxen et al. 2015b). The finding of paenilide, the first 
cereulide-like toxic compound produced by bacteria other than B. cereus sensu lato, 
pinpoints that the developed methods should be versatile and specific enough to 
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detect and differentiate between various cereulide variants and possible as yet 
unknown cereulide-like compounds. 
4.2.1.2. Effects of paenilide on mammalian cells and mitochondria 
The effect of paenilide (both compounds as a mixture) on mammalian cells was 
studied using porcine spermatozoa and kidney tubular epithelial cells (PK-15) as well 
as murine neuroblastoma (MNA). Exposure to subnanomolar amounts of paenilide 
led to various toxic effects in the test cells: loss of motility in the sperm cells, 
depolarization of mitochondria in sperm (Figure 8) and PK-15 cells, 
hyperpolarization of the plasma membrane in sperm cells (Figure 8), accelerated 
glucose consumption and metabolic acidosis in PK-15 cells, as well as cytolysis in 
PK-15 and MNA cells (Table 1 in Paper II). The toxicity equaled that of cereulide 
and homocereulide, indicating that low doses of paenilide could seriously damage 
human health, making paenilide a possibly potent food poisoning agent and bearing 
risks similar to those described for cereulide (Vangoitsenhoven et al. 2014, 
Vangoitsenhoven et al. 2015). 
 
Figure 8. Epifluorescence micrographs of boar spermatozoa displaying effects of 
exposure to paenilide. Epifluorescence micrographs of boar spermatozoa displaying 
effects of exposure to paenilide. The sperm cells were stained with the membrane 
potential-responsive fluorogenic dye JC-1, which fluoresces orange when membrane 
potential (∆Ψ) is high (>140 mV) and green when ∆Ψ is low (<100 mV). Panel A: 
Cells exposed to vehicle only (methanol) for 1 d. Panel B: Cells exposed to 0.4 ng 
ml-1 paenilide for 1 d with depolarized mitochondria in the mitochondrial sheath 
(diminished orange fluorescence compared to Panel A). Panel C: Cells exposed to 
1.3 ng ml-1 paenilide for 1 d displaying hyperpolarization in the head piece (orange 
fluorescence) and depolarization in the mitochondrial sheath (diminished orange 
fluorescence compared to Panel A). 
 
46 
In isolated rat liver mitochondria, paenilide acted as a potassium ionophore, which 
became saturated with K+ ions at a potassium ion concentration equivalent to that of 
blood plasma (4 mM) (Figure 7 in Paper II), and caused an influx of potassium ions, 
leading to swelling, a loss of mitochondrial membrane potential, uncoupling of 
oxidative phosphorylation and loss of respiratory control (Figures 3, 4, 5, and 6 in 
Paper II). Tests using black lipid membranes confirmed that paenilide acted as a 
potassium-specific carrier. These results showed that the detected toxic effects of 
paenilide on mammalian cells are explained by its functioning as a lipophilic cationic 
compound transporting K+ ions across cytoplasmic and mitochondrial membranes, 
similarly as cereulide and valinomycin (Mikkola et al. 1999, Teplova et al. 2006). 
Paenilide appears to be the first reported compound with high toxicity to mammalian 
cells produced by a member of the genus Paenibacillus. P. larvae, a significant honey 
bee pathogen, produces several toxic compounds with different modes of action 
which have been shown to have antifungal and antilarval effects (Fünfhaus et al. 
2013, Krska et al. 2015, Schild et al. 2014, Sood et al. 2014), and a strain of P. 
polymyxa has been reported to produce antifungal, insecticidal and herbicidal 
compounds (Zhao et al. 2011), but no report, other than Paper II of this thesis, of 
toxins relevant for mammalian health has so far been published. Traditionally, 
paenibacilli are not considered to cause any health risks. However, several species of 
Paenibacillus, including P. larvae and P. polymyxa, have been reported to cause 
bacteremia and pseudobacteremia in humans (Ko et al. 2008, Nasu et al. 2003, 
Noskin et al. 2001, Ouyang et al. 2008, Reboli et al. 1989, Rieg et al. 2010, Roux and 
Raoult 2004, Teng et al. 2003), indicating that they might be opportunistic pathogens. 
However, toxin production was not reported in any of the documented cases. 
4.2.2. Toxin-producing Streptomyces in cereal grains 
In the work presented in Paper IV, healthy-looking grains of barley and spring wheat, 
toxic in the BSMI assay, were found to harbor toxin-producing Streptomyces spp. 
The strains were isolated from randomly picked grains cultured on plates of tryptic 
soy agar. Figure 1 in Paper IV displays examples of grains with Streptomyces growth. 
The isolates were identified and grouped based on whole-cell fatty acid analysis, 
ribosomal DNA fingerprinting, and 16S rRNA gene sequencing. Eight isolates from 
the barley sample were identified as members of the Streptomyces albidoflavus group 
and ten isolates from the spring wheat sample as Streptomyces sp., most closely 
related to S. sedi. Of the eight barley isolates, six produced detectable amounts of 
antimycin A (Table 3 in Paper IV), a heat-stable macrolide antibiotic with no current 
clinical use due to its high toxicity. Quantifiable amounts of antimycin A were also 
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detected in a subsample of the barley grains prior to cultivation. Eight wheat isolates 
were highly toxic in the BSMI assay, but no known toxic substance was identified. 
These results show that streptomycetes may pose a novel threat for food and feed 
safety of stored grains. It is interesting to note that streptomycetes producing 
bioactive ionophoric compounds are being examined as possible biocontrol agents 
for controlling plant pathogens (Silva et al. 2014). If this type of use were to become 
common, the toxicity of these compounds towards mammalian cells, however, would 
need to be taken into account. 
The toxicity of antimycin A towards porcine kidney epithelial (PK-15) cells was 
compared to that of other grain-associated mitochondrial toxins, namely cereulide, 
paenilide, and enniatin B. As presented in Paper IV, antimycin A was more toxic than 
the mycotoxin enniatin B but less toxic than cereulide or paenilide. For all four toxins, 
mitochondrial damage (detected as loss of ∆Ψm and acceleration of glucose 
consumption) was observed at exposure concentrations lower than those triggering 
necrotic cell death (Table 4 in Paper IV). The acceleration of glucose consumption in 
conjunction with the loss of ∆Ψm points to the upregulation of glycolysis. Many types 
of mammalian cells are capable of upregulating ATP production via glycolysis in the 
absence of oxidative phosphorylation, a phenomenon known as the Crabtree effect 
(Lunt and Vander Heiden 2011). When glucose is available, these cells are less 
susceptible to mitochondrial damage than cells relying on oxidative phosphorylation 
(Marroquin et al. 2007). This explains why the PK-15 cells survived at low exposure 
concentrations despite mitochondrial dysfunction (Paper IV). 
However, not all cell types are able to survive solely on glycolytically produced ATP: 
for example, pancreatic beta cells lack this option and consequently become deprived 
of ATP if oxidative phosphorylation is blocked (Cantley et al. 2010, Maechler et al. 
2006, Sener and Malaisse 1987). Upon exposure of murine pancreatic beta cells 
(MIN6) to cereulide, antimycin A, enniatin B, or the antibacterial preservative 
triclosan, loss of ∆Ψm and cell death occurred at approximately the same exposure 
concentration without a detectable increase in glucose consumption (Ajao et al. 2015, 
Hoornstra et al. 2013, Kruglov et al. 2009, Tonshin et al. 2010, Vangoitsenhoven et 
al. 2014, and personal communication Maria A. Andersson 2014). Cell death 
following exposure to cereulide was reported apoptotic at extremely low exposure 
concentrations (≤0.5 ng ml-1) (Vangoitsenhoven et al. 2014) and necrotic at highly 
mitochondriotoxic concentrations (>0.4 μg ml-1) (Hoornstra et al. 2013). Apoptotic 
cell death requires ATP, so cells relying solely on mitochondria for energy production 
undergo necrotic cell death once mitochondrially produced ATP is depleted (Leist et 
al. 1997). As can be seen in Figure 9, MIN6 cells exposed to valinomycin underwent 
necrotic cell death at the same concentration where mitochondria became 
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depolarized, whereas cell types capable of switching to glycolytic ATP production 
(HaCaT and PK-15 cells) remained intact even when their mitochondria were 
depolarized. Similar results have been obtained with exposure to antimycin A, 
cereulide, enniatin B, myxothiazol, and triclosan (Ajao et al. 2015, Hoornstra et al. 
2013, Kruglov et al. 2009, Tonshin et al. 2010, and personal communication Maria 
A. Andersson 2014). Necrotic cell death triggers inflammatory responses by 
activating inflammasomes, which can cause tissue damage as well as accelerate the 
onset of both type 1 and type 2 diabetes (Rock et al. 2011). Mitochondrial dysfunction 
has directly been implicated in pancreatic damage connected to both type 1 and type 
2 diabetes (Maechler et al. 2006, Sivitz and Yorek 2010), the incidences of which are 
increasing worldwide (Canivell and Gomis 2014). Mitochondrial function is central 
in controlling insulin secretion from pancreatic beta cells by coupling glucose 
recognition to insulin secretion (Maechler et al. 2006). Continued low-dose exposure 
to heat-stable lipophilic mitochondrial toxins via staple foods such as grains could 
therefore explain at least part of the increase diabetes incidence, as has been 
suggested for cereulide (Vangoitsenhoven et al. 2015). 
The findings reported in Paper IV indicate that streptomycetes could pose a hitherto 
unidentified food safety risk. Streptomyces are ubiquitous in soil and common as 
endophytic symbionts or parasites in various types of plants (Seipke et al. 2012). 
They are well known as producers of secondary metabolites, many of which have 
bioactive properties (Berdy 2012). Even though many published studies report on the 
presence of streptomycetes in staple food crops (see references in Paper IV), little 
research concerning food safety risks related to streptomycetes is found in published 
literature. Streptomyces spp. are known to grow in media with even lower moisture 
levels than those required by most grain contaminating fungi, such as Fusarium, 
indicating that conditions preventing fungal growth and mycotoxin production cannot 
necessarily be assumed to control the growth and toxin production of Streptomyces. 
Antimycin A is not toxic to plants, as plant mitochondria can bypass the cytochrome 
b-dependent bc1 respiratory complex using an alternative oxidase which is unaffected 
by antimycin A (Millar et al. 2011). Thus, contamination cannot be detected based 
on grain or plant health. The possible connection between food contaminated with 
secondary metabolites of streptomycetes and the increasing incidence of diabetes, for 
example, is not as far-fetched as it may seem: known diabetogenic drugs, such as 
streptozotocin, bafilomycin A1, and concanamycin A, all produced by Streptomyces 
spp., have been proposed as environmental promoters of type 1 and 2 diabetes (Bodin 
et al. 2015, Hettiarachchi et al. 2006, Myers et al. 2003), and maternal exposure to 
macrolide antibiotics other than antimycin A has been shown to increase the type I 
diabetes risk of the unborn child (Kilkkinen et al. 2006).  
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4.3. Mammalian cell toxicity of microbially produced 
mitochondrial toxins 
The microbial toxins studied in this work represent chemically diverse compounds 
produced by different microbes, but they share the ability to cause mitochondrial 
dysfunction, albeit in various ways, and are produced by microbes capable of forming 
spores, i.e., capable of surviving in various less than optimal conditions. 
Mitochondrial toxicity leading to, e.g., liver failure and cardiovascular issues is the 
most common reason for market withdrawal of pharmaceuticals (Dykens and Will 
2007). In addition, mitochondrial damage has been linked to pathological conditions 
in many different human organs, such as the pancreas, heart, liver, kidneys and 
nervous system (Eirin et al., 2014). 
As can be seen from the results compiled in Table 7, the compounds studied in this 
thesis have toxic effects on many types of mammalian cells. In addition, cereulide, 
valinomycin, amylosin, and enniatin B can inhibit both bacterial and fungal growth 
(Paper III of this thesis and Ladeuze et al. 2011, Park et al. 2008, Roig et al. 2014, 
Tempelaars et al. 2011), possibly giving producers a competitive advantage in 
various environments and increasing the risk of exposure. 
The results presented in this thesis were obtained with pure compounds under 
laboratory conditions. In reality, we are repeatedly exposed to more than one 
compound at any given time. The possible synergistic or additive effects of chronic 
multi-compound exposure via food and indoor air are currently poorly understood. 
Studies on the effects of a Northern contaminant mixture (a mix of organic and 
inorganic environmental contaminants found in the blood of Canadian Inuits) have 
shown adverse effects on human coronary artery endothelial cells, pancreatic MIN6 
cells, and rat liver health, indicating a possible connection to the increased incidence 
of cardiovascular disease, diabetes, and non-alcoholic fatty liver disease among the 
exposed populations (Florian et al. 2013, Mailloux et al. 2014, Mailloux et al. 2015). 
The combined effects of exposure to multiple mitochondrial toxins via food and 
indoor air may have similar cumulative effects and therefore be more detrimental to 
human health than exposure to single compounds. It is worth noting that two of the 
studied mitochondrial toxins, cereulide and amylosin, have been found in both food 
and moisture-damaged indoor environments (Apetroaie-Constantin et al. 2009, 
Mikkola et al. 2004, Rajkovic 2014), indicating that exposure to a single compound 
could also occur through a combination of several sources. 
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5. Conclusions 
The conclusions based on the work presented in this thesis are:  
1. Chronic exposure via food or indoor environments to sub-lethal 
concentrations of mitochondrial toxins produced by microbes may be more 
common than has been understood so far. We may be exposed to a multitude 
of microbially produced mitochondrial toxins, the synergistic and/or additive 
effects of which are currently unknown. Chronic exposure to multiple 
toxicants may explain at least part of the increasing worldwide incidence of 
conditions such as diabetes, asthma, allergies, cardiovascular diseases, and 
autoimmune neurological disorders. 
2. Metabolites produced by spore-forming bacteria able to withstand adverse 
environmental conditions may pose a threat for human health. This work 
showed that spore-forming, toxin-producing bacteria belonging to the genera 
Bacillus, Paenibacillus, and Streptomyces can be present in food as well as 
indoor environments. 
3. Stored cereal grains can contain bacterial toxins in addition to mycotoxins. 
This type of food safety hazard is not currently recognized by legal food or 
feed safety requirements.  
4. The finding of paenilide, a cereulide-like heat-stable toxin produced by 
Paenibacillus tundrae even at chilled temperatures, presents a novel food 
safety hazard and shows that the genus Paenibacillus can no longer be 
considered harmless for human health. 
5. Streptomycetes growing in stored cereal grains can produce toxic secondary 
metabolites, such as shown in this thesis for antimycin A, bearing risks for 
food and feed safety. Due to the heat-stability of such metabolites, 
subsequent food processing steps are not sufficient to prevent the effects 
harmful to human and animal health. 
6. Amylosin, a mitochondrial toxin found in both moisture-damaged indoor 
environments and in food, directly affects cells of the human innate immune 
system, causing active cytokine release by most likely activating the NLRP3 
inflammasome. This reaction could explain some of the autoinflammation-
like symptoms experienced by inhabitants of moisture-damaged buildings 
where amylosin-producing bacteria are present. 
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7. Amylosin, similarly as cereulide and valinomycin, has both antifungal and 
antibacterial effects, which may therefore give bacteria producing these 
toxins a competitive advantage and promote their dominance in some 
moisture-damaged environments. 
8. The BSMI assay is an efficient and inexpensive method for rapid detection 
of mitochondrial toxicity of both aerosolized compounds and food stuffs. 
Combined with the collection of toxic aerosols, the BSMI assay may be 
useful as a screening method for airborne toxicity in moisture-damaged 
indoor environments. 
The findings of this thesis strongly support a recent call (Rajkovic 2014) for further 
research into the effects of repeated low-dose exposure as well as mixed simultaneous 
exposure to multiple compounds from one or more sources. Toxicity studies have 
traditionally focused on determining exposure threshold values at which acute and/or 
lethal symptoms appear and establishing safety limits based on these threshold 
values. In general, and especially when it comes to microbial toxins, less attention 
has been focused on examining the effects of chronic and sub-acute exposure. The 
standardized methods available for toxicity testing have mainly been developed for 
investigating the direct dose-response effects of exposure to inorganic chemicals, not 
the cumulative or multiplicative results of exposure to biochemical compounds, 
making it more challenging to study the toxicity of microbially produced compounds 
with these methods. 
This thesis also highlights the need for continuous vigilance and increased awareness 
in the food sector of the hazards and risks related especially to spore-forming 
microbes contaminating foods. Known risks as well as the existence of so far 
unknown potential hazards should be, for example, considered in the development of 
novel food processing techniques aimed at shelf-life extensions. 
In addition, the presented research indicates that bacteria and bacterial compounds 
may play a more significant role as causative agents of health problems experienced 
by inhabitants of moisture-damaged buildings than has thus far been understood. The 
majority of research concerning the microbial causes of building-related ill health 
symptoms has focused on fungi as causative agents. However, it appears that more 
attention should be paid also to bacteria and especially bacterial airborne toxins. 
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me becoming a hermit when I spent weekends home alone at the computer. Thank 
you for buying me candy and making me dinner and understanding that “a couple 
more minutes” in my mind meant something else in reality. All in all, thank you for 
being there for me. 
56 
I have a nagging feeling I might be forgetting someone here… 
 
 
 
 
Ah, of course! Douwe! Almost forgot you there ;) Thank you for being a good office 
roommate, making sure I didn’t lose my desk even when I wasn’t using it so much, 
and also thank you for organizing all those nights out with the MSS gang as well as 
ensuring that we always had enough chocolate cake. 
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